Mutually	O
exclusive	O
interaction	O
of	O
a	O
novel	O
matrix	B-protein
attachment	I-protein
region	I-protein
binding	I-protein
protein	I-protein
and	O
the	O
NF-muNR	B-protein
enhancer	I-protein
repressor	I-protein
.	O

Implications	O
for	O
regulation	O
of	O
immunoglobulin	B-protein
heavy	I-protein
chain	I-protein
expression	O
.	O

The	O
immunoglobulin	B-protein
heavy	I-protein
chain	I-protein
(	O
IgH	B-protein
)	O
intronic	O
enhancer	O
stimulates	O
transcription	O
from	O
functional	O
promoters	O
in	O
B	O
lymphocytes	O
but	O
not	O
other	O
cell	O
types	O
.	O

The	O
observation	O
that	O
binding	O
sites	O
for	O
the	O
nuclear	B-protein
factor-mu	I-protein
negative	I-protein
regulator	I-protein
(	I-protein
NF-muNR	I-protein
)	I-protein
enhancer	I-protein
repressor	I-protein
overlap	I-protein
nuclear	I-protein
matrix	I-protein
attachment	I-protein
regions	I-protein
(	O
MARs	B-protein
)	O
in	O
this	O
enhancer	B-DNA
has	O
lead	O
to	O
the	O
hypothesis	O
that	O
the	O
cell	O
type	O
specificity	O
of	O
the	O
enhancer	B-DNA
might	O
be	O
controlled	O
by	O
regulating	O
nuclear	O
matrix	O
attachment	O
(	O
Scheuermann	O
,	O
R.	O
H.	O
,	O
and	O
Chen	O
,	O
U.	O
(	O
1989	O
)	O
Genes	O
&	O
Dev.	O
3	O
,	O
1255-1266	O
)	O
.	O

To	O
understand	O
the	O
role	O
of	O
MARs	B-protein
in	O
IgH	B-DNA
enhancer	I-DNA
regulation	O
,	O
we	O
have	O
identified	O
a	O
novel	O
MAR-binding	B-protein
protein	I-protein
,	O
MAR-BP1	B-protein
,	O
from	O
soluble	O
nuclear	O
matrix	O
preparations	O
based	O
on	O
its	O
ability	O
to	O
bind	O
to	O
the	O
MARs	B-protein
associated	O
with	O
the	O
IgH	B-DNA
enhancer	I-DNA
.	O

Purified	O
MAR-BP1	B-protein
migrates	O
as	O
a	O
33-kDa	B-protein
protein	I-protein
,	O
and	O
it	O
can	O
be	O
found	O
in	O
nuclear	O
matrix	O
preparations	O
from	O
a	O
number	O
of	O
different	O
types	O
of	O
lymphoid	B-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

Although	O
specific	O
binding	O
sites	O
have	O
been	O
difficult	O
to	O
localize	O
by	O
chemical	O
or	O
enzymatic	O
footprinting	O
procedures	O
,	O
NF-muNR	B-protein
binding	O
sites	O
are	O
critical	O
for	O
efficient	O
MAR-BP1	B-protein
binding	O
.	O

Indeed	O
,	O
binding	O
of	O
the	O
IgH	B-DNA
enhancer	I-DNA
to	O
either	O
intact	O
nuclear	O
matrix	O
preparations	O
or	O
to	O
MAR-BP1	B-protein
is	O
mutually	O
exclusive	O
to	O
NF-muNR	B-protein
binding	O
.	O

These	O
results	O
are	O
consistent	O
with	O
a	O
model	O
for	O
cell-type	O
specific	O
regulation	O
in	O
which	O
binding	O
of	O
the	O
NF-muNR	B-protein
repressor	I-protein
to	O
the	O
IgH	B-DNA
enhancer	I-DNA
prevents	O
nuclear	O
matrix	O
attachment	O
in	O
inappropriate	O
cells	O
by	O
interfering	O
with	O
MAR-BP1	B-protein
/enhancer	B-DNA
interaction	O
.	O

THE	NULL
JoUrNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
Â©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

41	NULL
,	NULL
Issue	NULL
of	NULL
October	NULL
13	NULL
,	NULL
pp	NULL
.	NULL

24010-24018	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Mutually	NULL
Exclusive	NULL
Interaction	NULL
of	NULL
a	NULL
Novel	NULL
Matrix	NULL
Attachment	NULL
Region	NULL
Binding	NULL
Protein	NULL
and	NULL
the	NULL
NF-puNR	NULL
Enhancer	NULL
Repressor	NULL
IMPLICATIONS	NULL
FOR	NULL
REGULATION	NULL
OF	NULL
IMMUNOGLOBULIN	NULL
HEAVY	NULL
CHAIN	NULL
EXPRESSION*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
October	NULL
20	NULL
,	NULL
1994	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
July	NULL
13	NULL
,	NULL
1995	NULL
)	NULL
Rui-Ting	NULL
Zong	NULL
and	NULL
Richard	NULL
H.	NULL
Scheuermann	NULL
From	NULL
the	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Pathology	NULL
and	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
University	NULL
of	NULL
Texas	NULL
Southwestern	NULL
Medical	NULL
Center	NULL
,	NULL
Dallas	NULL
,	NULL
Texas	NULL
75235-9072	NULL
The	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
(	NULL
IgH	NULL
)	NULL
intronic	NULL
enhancer	NULL
stimulates	NULL
transcription	NULL
from	NULL
functional	NULL
promoters	NULL
in	NULL
B	NULL
lymphocytes	NULL
but	NULL
not	NULL
other	NULL
cell	NULL
types	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
nuclear	NULL
factor-pu	NULL
negative	NULL
regulator	NULL
(	NULL
NF-uNR	NULL
)	NULL
enhancer	NULL
repressor	NULL
overlap	NULL
nuclear	NULL
matrix	NULL
attachment	NULL
regions	NULL
(	NULL
MARs	NULL
)	NULL
in	NULL
this	NULL
enhancer	NULL
has	NULL
lead	NULL
to	NULL
the	NULL
hypothesis	NULL
that	NULL
the	NULL
cell	NULL
type	NULL
specificity	NULL
of	NULL
the	NULL
enhancer	NULL
might	NULL
be	NULL
controlled	NULL
by	NULL
regulating	NULL
nuclear	NULL
matrix	NULL
attachment	NULL
(	NULL
Scheuermann	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
and	NULL
Chen	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

3	NULL
,	NULL
1255-1266	NULL
)	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
role	NULL
of	NULL
MARs	NULL
in	NULL
IgH	NULL
enhancer	NULL
regulation	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
a	NULL
novel	NULL
MAR-binding	NULL
protein	NULL
,	NULL
MAR-BP1	NULL
,	NULL
from	NULL
soluble	NULL
nuclear	NULL
matrix	NULL
preparations	NULL
based	NULL
on	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
MARs	NULL
associated	NULL
with	NULL
the	NULL
IgH	NULL
enhancer	NULL
.	NULL

Purified	NULL
MAR-BP1	NULL
migrates	NULL
as	NULL
a	NULL
33-kDa	NULL
protein	NULL
,	NULL
and	NULL
it	NULL
can	NULL
be	NULL
found	NULL
in	NULL
nuclear	NULL
matrix	NULL
preparations	NULL
from	NULL
a	NULL
number	NULL
of	NULL
different	NULL
types	NULL
of	NULL
lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

Although	NULL
specific	NULL
binding	NULL
sites	NULL
have	NULL
been	NULL
difficult	NULL
to	NULL
localize	NULL
by	NULL
chemical	NULL
or	NULL
enzymatic	NULL
footprinting	NULL
proce-dures	NULL
,	NULL
NF-puNR	NULL
binding	NULL
sites	NULL
are	NULL
critical	NULL
for	NULL
efficient	NULL
MAR-BP1	NULL
binding	NULL
.	NULL

Indeed	NULL
,	NULL
binding	NULL
of	NULL
the	NULL
IgH	NULL
enhancer	NULL
to	NULL
either	NULL
intact	NULL
nuclear	NULL
matrix	NULL
preparations	NULL
or	NULL
to	NULL
MAR-BPI	NULL
is	NULL
mutually	NULL
exclusive	NULL
to	NULL
NF-uNR	NULL
binding	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
for	NULL
cell-type	NULL
specific	NULL
regulation	NULL
in	NULL
which	NULL
binding	NULL
of	NULL
the	NULL
NF-uNR	NULL
repressor	NULL
to	NULL
the	NULL
IgH	NULL
enhancer	NULL
prevents	NULL
nuclear	NULL
matrix	NULL
attachment	NULL
in	NULL
inappropriate	NULL
cells	NULL
by	NULL
interfering	NULL
with	NULL
MAR-BP1/en-hancer	NULL
interaction	NULL
.	NULL

Transcription	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
(	NULL
IgH	NULL
)	NULL
'	NULL
gene	NULL
is	NULL
influenced	NULL
by	NULL
at	NULL
least	NULL
two	NULL
distinct	NULL
classes	NULL
of	NULL
cis-acting	NULL
elements	NULL
,	NULL
promoters	NULL
and	NULL
enhancers	NULL
.	NULL

The	NULL
IgH	NULL
intronic	NULL
enhancer	NULL
,	NULL
located	NULL
between	NULL
the	NULL
Jy	NULL
elements	NULL
and	NULL
Cu	NULL
,	NULL
stimulates	NULL
transcription	NULL
from	NULL
promoters	NULL
in	NULL
a	NULL
relatively	NULL
distance-	NULL
and	NULL
ori-entation-independent	NULL
manner	NULL
,	NULL
and	NULL
acts	NULL
as	NULL
a	NULL
cell	NULL
type-specific	NULL
regulator	NULL
,	NULL
being	NULL
functional	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
nonfunctional	NULL
in	NULL
non-B	NULL
cells	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Staudt	NULL
and	NULL
Lenardo	NULL
(	NULL
1991	NULL
)	NULL
)	NULL
.	NULL

This	NULL
enhancer	NULL
contains	NULL
multiple	NULL
DNA	NULL
sequence	NULL
motifs	NULL
that	NULL
function	NULL
as	NULL
interaction	NULL
sites	NULL
for	NULL
sequence-specific	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

Many	NULL
of	NULL
these	NULL
sites	NULL
have	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
important	NULL
for	NULL
transcriptional	NULL
regulation	NULL
.	NULL

The	NULL
B	NULL
cell	NULL
specificity	NULL
of	NULL
the	NULL
IgH	NULL
enhancer	NULL
is	NULL
regulated	NULL
by	NULL
both	NULL
positively	NULL
and	NULL
negatively	NULL
acting	NULL
B	NULL
cell-specific	NULL
enhancer	NULL
elements	NULL
as	NULL
well	NULL
as	NULL
protein	NULL
*	NULL
This	NULL
work	NULL
has	NULL
been	NULL
supported	NULL
by	NULL
a	NULL
James	NULL
A.	NULL
Shannon	NULL
Director	NULL
's	NULL
Award	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
to	NULL
R.	NULL
H.	NULL
S.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

'The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IgH	NULL
,	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
;	NULL
NF-pNR	NULL
,	NULL
nuclear	NULL
factor-u	NULL
negative	NULL
regulator	NULL
;	NULL
MAR	NULL
,	NULL
matrix	NULL
attachment	NULL
region	NULL
;	NULL
kb	NULL
,	NULL
kilobase	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
MSA	NULL
,	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

protein	NULL
interactions	NULL
between	NULL
B	NULL
cell-specific	NULL
and	NULL
ubiquitously	NULL
expressed	NULL
nuclear	NULL
factors	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
negative	NULL
elements	NULL
in	NULL
the	NULL
IgH	NULL
enhancer	NULL
that	NULL
are	NULL
bound	NULL
by	NULL
a	NULL
nuclear	NULL
protein	NULL
,	NULL
nuclear	NULL
factor-u	NULL
negative	NULL
regulator	NULL
(	NULL
NF-pNR	NULL
)	NULL
.	NULL

NF-uNR	NULL
purified	NULL
from	NULL
a	NULL
preB	NULL
cell	NULL
line	NULL
binds	NULL
to	NULL
four	NULL
sites	NULL
flanking	NULL
the	NULL
enhancer	NULL
core	NULL
in	NULL
a	NULL
cooperative	NULL
manner	NULL
(	NULL
Scheuermann	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

NF-uNR	NULL
activity	NULL
is	NULL
expressed	NULL
in	NULL
non-B	NULL
cells	NULL
and	NULL
appears	NULL
to	NULL
repress	NULL
the	NULL
enhancer	NULL
in	NULL
these	NULL
inappropriate	NULL
cells	NULL
(	NULL
Scheuermann	NULL
and	NULL
Chen	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

One	NULL
intriguing	NULL
aspect	NULL
of	NULL
NF-pNR	NULL
binding	NULL
is	NULL
that	NULL
the	NULL
four	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
IgH	NULL
enhancer	NULL
overlap	NULL
two	NULL
nuclear	NULL
matrix	NULL
attachment	NULL
regions	NULL
(	NULL
MARs	NULL
)	NULL
(	NULL
Cockerill	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

MARs	NULL
are	NULL
AT-rich	NULL
DNA	NULL
sequences	NULL
that	NULL
remain	NULL
attached	NULL
to	NULL
a	NULL
salt-resistant	NULL
nuclear	NULL
structure	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
nuclear	NULL
matrix	NULL
or	NULL
scaffold	NULL
(	NULL
Berezney	NULL
and	NULL
Coffey	NULL
,	NULL
1974	NULL
)	NULL
.	NULL

MARs/scaffold	NULL
attachment	NULL
regions	NULL
have	NULL
been	NULL
mapped	NULL
to	NULL
DNA	NULL
segments	NULL
that	NULL
are	NULL
several	NULL
hundred	NULL
base	NULL
pairs	NULL
in	NULL
length	NULL
(	NULL
Gasser	NULL
and	NULL
Laemmli	NULL
,	NULL
1986	NULL
;	NULL
Cockerill	NULL
and	NULL
Garrard	NULL
,	NULL
1986	NULL
)	NULL
,	NULL
which	NULL
anchor	NULL
chromatin	NULL
loops	NULL
to	NULL
the	NULL
nuclear	NULL
matrix	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Laemmli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Juxtaposition	NULL
or	NULL
cohabitation	NULL
of	NULL
MARs	NULL
with	NULL
transcriptional	NULL
regulatory	NULL
elements	NULL
suggests	NULL
that	NULL
MARs	NULL
may	NULL
influence	NULL
transcription	NULL
(	NULL
Cockerill	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
some	NULL
MAR	NULL
sequences	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
stimulate	NULL
transcription	NULL
in	NULL
trans-fection	NULL
studies	NULL
(	NULL
Stief	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Xu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Phi-Van	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Klehr	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Bode	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
IgH	NULL
enhancer	NULL
MARs	NULL
to	NULL
enhancer	NULL
activity	NULL
has	NULL
recently	NULL
been	NULL
demonstrated	NULL
in	NULL
transgenic	NULL
mouse	NULL
experiments	NULL
where	NULL
constructs	NULL
lacking	NULL
these	NULL
MARs	NULL
were	NULL
inactive	NULL
(	NULL
Forrester	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Several	NULL
MAR-binding	NULL
proteins	NULL
have	NULL
been	NULL
identified	NULL
and	NULL
purified	NULL
from	NULL
nuclear	NULL
extracts	NULL
(	NULL
von	NULL
Kries	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
,	NULL
1994	NULL
;	NULL
Tsutsui	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
von	NULL
Kries	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Some	NULL
of	NULL
these	NULL
proteins	NULL
require	NULL
relatively	NULL
long	NULL
DNA	NULL
fragments	NULL
for	NULL
efficient	NULL
binding	NULL
and	NULL
may	NULL
recognize	NULL
certain	NULL
structural	NULL
features	NULL
of	NULL
DNA	NULL
rather	NULL
than	NULL
a	NULL
precise	NULL
nucleotide	NULL
sequence	NULL
(	NULL
Zhao	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Others	NULL
may	NULL
have	NULL
the	NULL
properties	NULL
similar	NULL
to	NULL
transcription	NULL
factors	NULL
(	NULL
Dickinson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Bidwell	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
since	NULL
they	NULL
recognize	NULL
specific	NULL
sequences	NULL
within	NULL
DNA	NULL
fragments	NULL
.	NULL

Proteins	NULL
binding	NULL
to	NULL
MARs	NULL
include	NULL
lamin	NULL
B1	NULL
and	NULL
topoisomerase	NULL
II	NULL
,	NULL
which	NULL
are	NULL
major	NULL
components	NULL
of	NULL
the	NULL
nuclear	NULL
matrix	NULL
(	NULL
Luderus	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Sperry	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
;	NULL
the	NULL
yeast	NULL
RAP-1	NULL
factor	NULL
and	NULL
Hela	NULL
SAF-A/	NULL
hnRNP-U	NULL
,	NULL
which	NULL
induce	NULL
DNA	NULL
loop	NULL
formation	NULL
(	NULL
Hofmann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Romig	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Fackelmayer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
;	NULL
and	NULL
SATB1	NULL
and	NULL
nucleolin	NULL
,	NULL
which	NULL
seems	NULL
to	NULL
preferentially	NULL
bind	NULL
DNA	NULL
with	NULL
base-unpairing	NULL
potential	NULL
(	NULL
Dickinson	NULL
and	NULL
Kohwi-Shigematsu	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
describe	NULL
the	NULL
identification	NULL
and	NULL
purification	NULL
of	NULL
a	NULL
novel	NULL
33-kDa	NULL
nuclear	NULL
matrix	NULL
protein	NULL
,	NULL
MAR-BP1	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
IgH	NULL
enhancer	NULL
MARs	NULL
.	NULL

Binding	NULL
of	NULL
MAR-BP1	NULL
to	NULL
the	NULL
IgH	NULL
enhancer	NULL
MARs	NULL
requires	NULL
the	NULL
four	NULL
NF-uNR	NULL
binding	NULL
sites	NULL
.	NULL

Indeed	NULL
,	NULL
binding	NULL
of	NULL
MAR-BP1	NULL
and	NULL
NF-uNR	NULL
to	NULL
IgH	NULL
enhancer	NULL
frag-	NULL
24010	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10Â°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
MAR	NULL
Binding	NULL
and	NULL
IgH	NULL
Enhancer	NULL
Regulation	NULL
ments	NULL
is	NULL
mutually	NULL
exclusive	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
for	NULL
cell	NULL
type-specific	NULL
regulation	NULL
in	NULL
which	NULL
NF-uNR	NULL
binding	NULL
to	NULL
the	NULL
IgH	NULL
enhancer	NULL
prevents	NULL
nuclear	NULL
matrix	NULL
attachment	NULL
by	NULL
interfering	NULL
with	NULL
interaction	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
DNA	NULL
Probes-The	NULL
1.0-kb	NULL
Xbal	NULL
restriction	NULL
fragment	NULL
containing	NULL
the	NULL
entire	NULL
mouse	NULL
IgH	NULL
intronic	NULL
enhancer	NULL
and	NULL
p1.2	NULL
,	NULL
a	NULL
HindIII	NULL
fragment	NULL
from	NULL
mouse	NULL
Cu	NULL
,	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
Scheuermann	NULL
and	NULL
Chen	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
3'-En	NULL
fragment	NULL
(	NULL
809	NULL
bp	NULL
)	NULL
is	NULL
derived	NULL
from	NULL
the	NULL
enhancer	NULL
by	NULL
digestion	NULL
with	NULL
Xbal	NULL
and	NULL
EcoRI	NULL
.	NULL

The	NULL
5'-En	NULL
fragment	NULL
(	NULL
381	NULL
bp	NULL
)	NULL
is	NULL
derived	NULL
by	NULL
digestion	NULL
with	NULL
Xbal	NULL
and	NULL
Pvull	NULL
.	NULL

The	NULL
MbolI	NULL
5'-En	NULL
fragment	NULL
(	NULL
301	NULL
bp	NULL
)	NULL
is	NULL
prepared	NULL
by	NULL
digestion	NULL
of	NULL
5'-En	NULL
with	NULL
Mboll	NULL
removing	NULL
80	NULL
bp	NULL
from	NULL
the	NULL
5'-end	NULL
.	NULL

The	NULL
0.92-kb	NULL
k	NULL
MAR	NULL
and	NULL
0.66-kb	NULL
Drosophila	NULL
histone	NULL
spacer	NULL
MAR	NULL
were	NULL
gifts	NULL
from	NULL
W.	NULL
Garrard	NULL
(	NULL
U.T	NULL
.	NULL

Southwestern	NULL
Medical	NULL
Center	NULL
)	NULL
.	NULL

The	NULL
mutant	NULL
versions	NULL
of	NULL
the	NULL
IgH	NULL
enhancer	NULL
containing	NULL
NF-uNR	NULL
binding	NULL
site	NULL
deletions	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
Scheuermann	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
Nuclei	NULL
and	NULL
Nuclear	NULL
Matrix-The	NULL
WEHI-231	NULL
mature	NULL
B	NULL
cell	NULL
line	NULL
was	NULL
grown	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Scheuermann	NULL
and	NULL
Chen	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
Nonidet	NULL
P-40	NULL
,	NULL
and	NULL
nuclei	NULL
were	NULL
prepared	NULL
by	NULL
centrifugation	NULL
through	NULL
a	NULL
sucrose	NULL
cushion	NULL
as	NULL
described	NULL
by	NULL
Berezney	NULL
and	NULL
Coffey	NULL
(	NULL
1974	NULL
)	NULL
.	NULL

Nuclear	NULL
matrix	NULL
was	NULL
prepared	NULL
from	NULL
the	NULL
purified	NULL
nuclei	NULL
by	NULL
a	NULL
high	NULL
salt	NULL
extraction	NULL
method	NULL
(	NULL
Cockerill	NULL
and	NULL
Garrard	NULL
,	NULL
1986	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
Total	NULL
Soluble	NULL
Nuclear	NULL
Matrix	NULL
Proteins-Soluble	NULL
nuclear	NULL
matrix	NULL
proteins	NULL
were	NULL
prepared	NULL
by	NULL
a	NULL
denaturation-renaturation	NULL
process	NULL
.	NULL

Generally	NULL
,	NULL
50	NULL
mg	NULL
of	NULL
nuclear	NULL
matrix	NULL
was	NULL
dissolved	NULL
in	NULL
25	NULL
ml	NULL
of	NULL
Denaturation	NULL
Buffer	NULL
(	NULL
100	NULL
mm	NULL
NaCl	NULL
,	NULL
20	NULL
mm	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
8	NULL
M	NULL
urea	NULL
)	NULL
.	NULL

After	NULL
a	NULL
10-min	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
insoluble	NULL
material	NULL
was	NULL
removed	NULL
by	NULL
centrifugation	NULL
at	NULL
10,000	NULL
x	NULL
g	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4Â°C	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
first	NULL
dialyzed	NULL
against	NULL
Renaturation	NULL
Buffer	NULL
(	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
20	NULL
mm	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
)	NULL
containing	NULL
1	NULL
M	NULL
urea	NULL
for	NULL
3	NULL
h	NULL
and	NULL
then	NULL
against	NULL
Renaturation	NULL
Buffer	NULL
without	NULL
urea	NULL
for	NULL
an	NULL
additional	NULL
3	NULL
h	NULL
at	NULL
4	NULL
Â°C	NULL
.	NULL

After	NULL
10	NULL
min	NULL
of	NULL
centrifugation	NULL
at	NULL
4	NULL
Â°C	NULL
to	NULL
clarify	NULL
,	NULL
the	NULL
supernatant	NULL
(	NULL
soluble	NULL
nuclear	NULL
matrix	NULL
)	NULL
was	NULL
frozen	NULL
in	NULL
liquid	NULL
N	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-80	NULL
Â°C	NULL
.	NULL

By	NULL
this	NULL
protocol	NULL
,	NULL
40-50	NULL
%	NULL
of	NULL
the	NULL
matrix	NULL
protein	NULL
remained	NULL
soluble	NULL
following	NULL
renaturation	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
a	NULL
dye-binding	NULL
assay	NULL
(	NULL
Bradford	NULL
,	NULL
1976	NULL
)	NULL
.	NULL

Purification	NULL
of	NULL
MAR-Binding	NULL
Protein-To	NULL
fractionate	NULL
nuclear	NULL
matrix	NULL
proteins	NULL
,	NULL
the	NULL
soluble	NULL
nuclear	NULL
matrix	NULL
preparation	NULL
was	NULL
applied	NULL
to	NULL
a	NULL
CM-Sepharose	NULL
column	NULL
,	NULL
and	NULL
proteins	NULL
were	NULL
eluted	NULL
with	NULL
a	NULL
salt	NULL
gradient	NULL
.	NULL

Fractions	NULL
with	NULL
MAR-binding	NULL
activity	NULL
,	NULL
as	NULL
assessed	NULL
using	NULL
a	NULL
mobility	NULL
shift	NULL
assay	NULL
with	NULL
IgH	NULL
enhancer	NULL
fragments	NULL
as	NULL
probes	NULL
,	NULL
were	NULL
pooled	NULL
and	NULL
loaded	NULL
on	NULL
a	NULL
DEAE-Sepharose	NULL
column	NULL
in	NULL
Renaturation	NULL
Buffer	NULL
.	NULL

The	NULL
MAR-binding	NULL
activity	NULL
was	NULL
eluted	NULL
with	NULL
a	NULL
NaCl	NULL
gradient	NULL
.	NULL

Fractions	NULL
with	NULL
>	NULL
50	NULL
%	NULL
peak	NULL
binding	NULL
activity	NULL
(	NULL
between	NULL
0.3	NULL
and	NULL
0.7	NULL
m	NULL
NaCl	NULL
)	NULL
were	NULL
pooled	NULL
and	NULL
dialyzed	NULL
against	NULL
Renaturation	NULL
Buffer	NULL
for	NULL
at	NULL
least	NULL
3	NULL
h.	NULL
The	NULL
dialyzed	NULL
DEAE	NULL
pool	NULL
was	NULL
applied	NULL
to	NULL
a	NULL
double-stranded	NULL
DNA-cellulose	NULL
affinity	NULL
column	NULL
in	NULL
Renaturation	NULL
Buffer	NULL
.	NULL

MAR-binding	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
fractions	NULL
eluted	NULL
with	NULL
0.3-0.5	NULL
M	NULL
NaCl	NULL
.	NULL

The	NULL
purified	NULL
MAR-binding	NULL
protein	NULL
was	NULL
dialyzed	NULL
,	NULL
frozen	NULL
in	NULL
liquid	NULL
N	NULL
,	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-80	NULL
Â°C	NULL
.	NULL

Matrix	NULL
DNA	NULL
Binding	NULL
Assay-A	NULL
standard	NULL
in	NULL
vitro	NULL
MAR	NULL
binding	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Cockerill	NULL
and	NULL
Garrard	NULL
,	NULL
1986	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
matrices	NULL
were	NULL
washed	NULL
3	NULL
times	NULL
in	NULL
Washing	NULL
Buffer	NULL
(	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
0.25	NULL
mg/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
)	NULL
.	NULL

Binding	NULL
was	NULL
performed	NULL
by	NULL
incubation	NULL
of	NULL
10	NULL
pl	NULL
of	NULL
nuclear	NULL
matrix	NULL
(	NULL
~5	NULL
ug	NULL
of	NULL
matrix	NULL
protein	NULL
)	NULL
with	NULL
90	NULL
ul	NULL
of	NULL
Assay	NULL
Solution	NULL
(	NULL
50	NULL
mm	NULL
NaCl	NULL
,	NULL
2	NULL
mm	NULL
EDTA	NULL
,	NULL
10	NULL
mm	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
0.5	NULL
mM	NULL
phenyImethylsulfony	NULL
]	NULL
fluoride	NULL
,	NULL
10	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
5	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
0.25	NULL
mg/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
1-2	NULL
ng	NULL
of	NULL
DNA	NULL
fragments	NULL
,	NULL
and	NULL
20	NULL
ug	NULL
of	NULL
unlabeled	NULL
,	NULL
sonicated	NULL
Escherichia	NULL
coli	NULL
DNA	NULL
)	NULL
shaking	NULL
for	NULL
1	NULL
h	NULL
at	NULL
23	NULL
Â°C	NULL
.	NULL

DNA	NULL
fragments	NULL
that	NULL
interact	NULL
with	NULL
the	NULL
matrix	NULL
were	NULL
separated	NULL
from	NULL
free	NULL
DNA	NULL
by	NULL
10	NULL
min	NULL
of	NULL
centrifugation	NULL
at	NULL
10,000	NULL
x	NULL
g	NULL
at	NULL
4	NULL
Â°C	NULL
.	NULL

After	NULL
washing	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
Final	NULL
Washing	NULL
Buffer	NULL
(	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
2	NULL
mm	NULL
EDTA	NULL
,	NULL
10	NULL
mm	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
0.25	NULL
mg/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
)	NULL
,	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
solubilized	NULL
in	NULL
15	NULL
ul	NULL
of	NULL
Solubilizing	NULL
Buffer	NULL
(	NULL
2	NULL
mm	NULL
EDTA	NULL
,	NULL
40	NULL
mM	NULL
Tris	NULL
acetate	NULL
,	NULL
0.4	NULL
mg/ml	NULL
pro-teinase	NULL
K	NULL
,	NULL
0.5	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
5	NULL
ug/ml	NULL
sonicated	NULL
salmon	NULL
sperm	NULL
DNA	NULL
)	NULL
and	NULL
incubated	NULL
overnight	NULL
at	NULL
37	NULL
Â°C	NULL
.	NULL

Resulting	NULL
matrix-bound	NULL
DNA	NULL
fragments	NULL
were	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
on	NULL
1.5	NULL
%	NULL
agarose	NULL
alongside	NULL
a	NULL
sample	NULL
of	NULL
probe	NULL
DNA	NULL
representing	NULL
25	NULL
%	NULL
of	NULL
that	NULL
used	NULL
in	NULL
the	NULL
initial	NULL
reaction	NULL
.	NULL

In	NULL
protein	NULL
competition	NULL
experiments	NULL
,	NULL
*Â°P-labeled	NULL
DNA	NULL
fragments	NULL
(	NULL
~2	NULL
ng	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
purified	NULL
NF-uNR	NULL
,	NULL
purified	NULL
MAR-BP1	NULL
,	NULL
or	NULL
soluble	NULL
matrix	NULL
proteins	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
sonicated	NULL
E.	NULL
coli	NULL
DNA	NULL
as	NULL
a	NULL
nonspecific	NULL
competitor	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
the	NULL
additions	NULL
of	NULL
15	NULL
ug	NULL
sonicated	NULL
E.	NULL
coli	NULL
DNA	NULL
and	NULL
5	NULL
ug	NULL
nuclear	NULL
matrix	NULL
,	NULL
the	NULL
solution	NULL
was	NULL
incubated	NULL
shaking	NULL
for	NULL
one	NULL
hour	NULL
at	NULL
23	NULL
Â°C	NULL
and	NULL
processed	NULL
as	NULL
described	NULL
24011	NULL
A	NULL
5Â°	NULL
MAR	NULL
3	NULL
!	NULL

MAR	NULL
L	NULL
L	NULL
LLLLLLLLLLLLLLLLLLLLLLLA	NULL
Xbal	NULL
Pvull	NULL
EcoRI	NULL
Xbal	NULL
I	NULL
|	NULL
I	NULL
|	NULL
I	NULL
I	NULL
I	NULL
I	NULL
5-En	NULL
core	NULL
3-En	NULL
B	NULL
IP	NULL
0	NULL
0.2	NULL
IP	NULL
0	NULL
0.2	NULL
IP	NULL
0	NULL
9.2	NULL
Competitor	NULL
(	NULL
ug/u1	NULL
)	NULL
am	NULL
-	NULL
-pUC19	NULL
ap	NULL
--	NULL
-pUC19	NULL
#	NULL
@	NULL
~-	NULL
__	NULL
-u12	NULL
Gp	NULL
Â«	NULL
w-	NULL
-	NULL
a	NULL
Â»	NULL
-svar	NULL
@	NULL
@	NULL
*	NULL
-ighe	NULL
10	NULL
2	NULL
3	NULL
4	NULL
50	NULL
O6	NULL
7	NULL
B	NULL
9	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Specific	NULL
binding	NULL
of	NULL
[	NULL
gH	NULL
enhancer	NULL
to	NULL
the	NULL
nuclear	NULL
matrix	NULL
.	NULL

A	NULL
,	NULL
MAR	NULL
sequences	NULL
and	NULL
NF-uNR	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
IgH	NULL
enhancer	NULL
fragment	NULL
.	NULL

The	NULL
entire	NULL
tissue-specific	NULL
IgH	NULL
enhancer	NULL
is	NULL
contained	NULL
within	NULL
a	NULL
1.0-kb	NULL
Xbal	NULL
restriction	NULL
fragment	NULL
.	NULL

The	NULL
fragment	NULL
can	NULL
be	NULL
subdivided	NULL
by	NULL
digestion	NULL
with	NULL
Puull	NULL
and	NULL
EcoRI	NULL
giving	NULL
the	NULL
5'-En	NULL
,	NULL
enhancer	NULL
core	NULL
,	NULL
and	NULL
3'-En	NULL
fragments	NULL
.	NULL

The	NULL
MARs	NULL
located	NULL
5	NULL
``	NULL
and	NULL
3	NULL
'	NULL
of	NULL
the	NULL
enhancer	NULL
are	NULL
shown	NULL
by	NULL
hatched	NULL
bars	NULL
.	NULL

The	NULL
four	NULL
binding	NULL
sites	NULL
of	NULL
the	NULL
NF-uNR	NULL
enhancer	NULL
repressor	NULL
protein	NULL
flanking	NULL
the	NULL
enhancer	NULL
core	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
open	NULL
rectangles	NULL
(	NULL
P1-P4	NULL
)	NULL
.	NULL

Other	NULL
sites	NULL
thought	NULL
to	NULL
be	NULL
important	NULL
for	NULL
enhancer	NULL
function	NULL
(	NULL
see	NULL
Staudt	NULL
and	NULL
Lenardo	NULL
(	NULL
1991	NULL
)	NULL
)	NULL
are	NULL
also	NULL
indicated	NULL
,	NULL
including	NULL
E	NULL
boxes	NULL
(	NULL
1-5	NULL
)	NULL
,	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
nuclear	NULL
protein	NULL
Ig-EBP	NULL
(	NULL
E	NULL
and	NULL
E	NULL
``	NULL
)	NULL
,	NULL
the	NULL
octamer	NULL
(	NULL
0	NULL
)	NULL
and	NULL
pB	NULL
sites	NULL
,	NULL
and	NULL
consensus	NULL
sequences	NULL
for	NULL
nuclear	NULL
matrix	NULL
attachment	NULL
(	NULL
M	NULL
)	NULL
.	NULL

B	NULL
,	NULL
nuclear	NULL
matrix	NULL
attachment	NULL
of	NULL
enhancer	NULL
fragments	NULL
.	NULL

Mixtures	NULL
of	NULL
*Â°P-labeled	NULL
DNAs	NULL
,	NULL
including	NULL
pUC19	NULL
,	NULL
a	NULL
fragment	NULL
derived	NULL
from	NULL
the	NULL
Ig	NULL
u	NULL
heavy	NULL
chain	NULL
constant	NULL
region	NULL
(	NULL
1.2	NULL
)	NULL
,	NULL
the	NULL
0.92-kb	NULL
k	NULL
light	NULL
chain	NULL
MAR	NULL
(	NULL
Â«	NULL
xMAR	NULL
)	NULL
,	NULL
and	NULL
the	NULL
1.0-kb	NULL
Xbal	NULL
IgH	NULL
enhancer	NULL
(	NULL
IgHE	NULL
)	NULL
fragment	NULL
,	NULL
were	NULL
incubated	NULL
with	NULL
insoluble	NULL
nuclear	NULL
matrix	NULL
preparations	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
E.	NULL
coli	NULL
competitor	NULL
DNA	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
matrix-associated	NULL
DNA	NULL
using	NULL
mixtures	NULL
of	NULL
the	NULL
IgH	NULL
enhancer	NULL
and	NULL
pUC19	NULL
(	NULL
Zanes	NULL
1-3	NULL
)	NULL
,	NULL
the	NULL
x	NULL
MAR	NULL
,	NULL
and	NULL
pUC19	NULL
(	NULL
Zanes	NULL
4-6	NULL
)	NULL
and	NULL
the	NULL
IgH	NULL
enhancer	NULL
and	NULL
u1.2	NULL
(	NULL
lanes	NULL
7-9	NULL
)	NULL
was	NULL
analyzed	NULL
by	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
binding	NULL
is	NULL
compared	NULL
with	NULL
lanes	NULL
containing	NULL
25	NULL
%	NULL
of	NULL
the	NULL
DNA	NULL
input	NULL
(	NULL
IP	NULL
)	NULL
used	NULL
in	NULL
each	NULL
reaction	NULL
(	NULL
Zanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
and	NULL
7	NULL
)	NULL
.	NULL

above	NULL
.	NULL

Mobility	NULL
Shift	NULL
Assays	NULL
(	NULL
MSAs	NULL
)	NULL
-DNA	NULL
binding	NULL
assays	NULL
(	NULL
Garner	NULL
and	NULL
Revzin	NULL
,	NULL
1981	NULL
;	NULL
Fried	NULL
and	NULL
Crothers	NULL
,	NULL
1981	NULL
)	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Scheuermann	NULL
and	NULL
Chen	NULL
,	NULL
1989	NULL
)	NULL
with	NULL
the	NULL
following	NULL
modifica-tions	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
done	NULL
in	NULL
25	NULL
wl	NULL
,	NULL
total	NULL
volume	NULL
,	NULL
containing	NULL
~0.5	NULL
ng	NULL
of	NULL
*Â°P-end-labeled	NULL
DNA	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI/dC	NULL
)	NULL
,	NULL
and	NULL
protein	NULL
fractions	NULL
in	NULL
Binding	NULL
Buffer	NULL
(	NULL
10	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
100	NULL
mm	NULL
NaCl	NULL
,	NULL
0.5	NULL
mm	NULL
EDTA	NULL
,	NULL
0.02	NULL
%	NULL
Tween	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
)	NULL
.	NULL

After	NULL
25	NULL
min	NULL
of	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
samples	NULL
were	NULL
electrophoresed	NULL
through	NULL
4	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
0.5	NULL
X	NULL
TGE	NULL
(	NULL
25	NULL
mm	NULL
Tris	NULL
base	NULL
,	NULL
190	NULL
mM	NULL
glycine	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
at	NULL
4	NULL
Â°C	NULL
.	NULL

Free	NULL
and	NULL
complexed	NULL
DNA	NULL
was	NULL
quantified	NULL
following	NULL
fixation	NULL
with	NULL
10	NULL
%	NULL
methanol	NULL
,	NULL
10	NULL
%	NULL
acetic	NULL
acid	NULL
and	NULL
drying	NULL
using	NULL
a	NULL
Phos-phorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

UV	NULL
Cross-linking-UV-cross-linking	NULL
experiments	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Scheuermann	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

After	NULL
UV	NULL
irradiation	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
digested	NULL
with	NULL
30	NULL
pg	NULL
of	NULL
DNase	NULL
I	NULL
at	NULL
23	NULL
Â°C	NULL
for	NULL
30	NULL
min	NULL
and	NULL
loaded	NULL
on	NULL
an	NULL
11	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
.	NULL

Denaturing	NULL
Gel	NULL
Electrophoresis-Standard	NULL
discontinuous	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
was	NULL
used	NULL
1970	NULL
)	NULL
.	NULL

RESULTS	NULL
Nuclear	NULL
Matrix	NULL
Binds	NULL
Specifically	NULL
to	NULL
the	NULL
IgH	NULL
Enhancer-The	NULL
IgH	NULL
enhancer	NULL
contains	NULL
the	NULL
DNA	NULL
recognition	NULL
sites	NULL
for	NULL
a	NULL
variety	NULL
of	NULL
different	NULL
nuclear	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
,	NULL
including	NULL
an	NULL
octamer	NULL
motif	NULL
,	NULL
several	NULL
E	NULL
boxes	NULL
,	NULL
and	NULL
four	NULL
binding	NULL
sites	NULL
for	NULL
NF-uNR	NULL
(	NULL
P1-P4	NULL
)	NULL
.	NULL

The	NULL
1.0-kb	NULL
Xbal	NULL
enhancer	NULL
fragment	NULL
can	NULL
be	NULL
subdivided	NULL
into	NULL
three	NULL
pieces	NULL
,	NULL
the	NULL
5'-En	NULL
,	NULL
core	NULL
,	NULL
and	NULL
3'-En	NULL
fragments	NULL
by	NULL
restriction	NULL
enzyme	NULL
digestion	NULL
.	NULL

The	NULL
5'-Ein	NULL
and	NULL
3'-En	NULL
fragments	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10Â°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
&	NULL
t	NULL
A	NULL
3	NULL
s	NULL
&	NULL
T	NULL
9	NULL
5	NULL
Â£	NULL
5	NULL
;	NULL
@	NULL
6	NULL
Â£	NULL
a	NULL
9	NULL
En	NULL
:	NULL
5	NULL
9	NULL
g	NULL
5	NULL
nugm	NULL
>	NULL
g	NULL
c	NULL
2	NULL
<	NULL
.	NULL

00mgazygs	NULL
Competitor	NULL
Z	NULL
Z	NULL
w	NULL
2	NULL
oa	NULL
uw	NULL
o	NULL
o	NULL
#	NULL
Â®	NULL
the	NULL
Gap	NULL
#	NULL
Froe	NULL
prove	NULL
-	NULL
CGR	NULL
00	NULL
Cb	NULL
anm	NULL
am	NULL
10203	NULL
40	NULL
50	NULL
60	NULL
7	NULL
8	NULL
9	NULL
9	NULL
x	NULL
.	NULL

B	NULL
2	NULL
Â§	NULL
5	NULL
Â§	NULL
Â°	NULL
Â£500	NULL
Â§	NULL
;	NULL
2	NULL
6	NULL
6	NULL
E	NULL
1	NULL
$	NULL
0	NULL
&	NULL
Â£00	NULL
=	NULL
C	NULL
ic	NULL
aA	NULL
0	NULL
c	NULL
ou	NULL
5	NULL
Â§	NULL
oc	NULL
2	NULL
<	NULL
oI	NULL
g	NULL
Â£	NULL
wos	NULL
2	NULL
.	NULL

o	NULL
o	NULL
5	NULL
8	NULL
R	NULL
``	NULL
&	NULL
Competitor	NULL
Z	NULL
2	NULL
Â®	NULL
2	NULL
i	NULL
i	NULL
ia	NULL
O	NULL
z	NULL
p	NULL
qk	NULL
wa	NULL
tot	NULL
b4	NULL
i	NULL
s	NULL
tes	NULL
Free	NULL
probe	NULL
1	NULL
2	NULL
8B	NULL
4	NULL
506	NULL
7	NULL
8	NULL
s	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
soluble	NULL
MAR-binding	NULL
protein	NULL
.	NULL

A	NULL
,	NULL
0.5-ng	NULL
*Â°P-labeled	NULL
5'-En	NULL
DNA	NULL
was	NULL
incubated	NULL
with	NULL
0.5	NULL
ug	NULL
of	NULL
soluble	NULL
matrix	NULL
protein	NULL
,	NULL
and	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
analyzed	NULL
by	NULL
MSA	NULL
.	NULL

Lane	NULL
1	NULL
contains	NULL
the	NULL
labeled	NULL
probe	NULL
without	NULL
matrix	NULL
protein	NULL
;	NULL
lames	NULL
3-9	NULL
contain	NULL
a	NULL
200-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
DNA	NULL
competitor	NULL
as	NULL
indicated	NULL
,	NULL
except	NULL
that	NULL
poly	NULL
(	NULL
dA/dT	NULL
)	NULL
was	NULL
used	NULL
in	NULL
a	NULL
2000-fold	NULL
molar	NULL
excess	NULL
.	NULL

The	NULL
MAR-BPI-DNA	NULL
complex	NULL
is	NULL
indicated	NULL
with	NULL
an	NULL
arrow	NULL
.	NULL

B	NULL
,	NULL
as	NULL
in	NULL
A	NULL
except	NULL
that	NULL
the	NULL
3'-Ein	NULL
fragment	NULL
was	NULL
used	NULL
as	NULL
a	NULL
labeled	NULL
probe	NULL
.	NULL

have	NULL
been	NULL
found	NULL
to	NULL
specifically	NULL
interact	NULL
with	NULL
the	NULL
nuclear	NULL
matrix	NULL
(	NULL
Cockerill	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
and	NULL
thus	NULL
contain	NULL
MARs	NULL
.	NULL

Nuclear	NULL
matrix	NULL
preparations	NULL
from	NULL
a	NULL
B	NULL
cell	NULL
line	NULL
were	NULL
found	NULL
to	NULL
specifically	NULL
bind	NULL
IgH	NULL
enhancer	NULL
DNA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
excess	NULL
of	NULL
nonspecific	NULL
K.	NULL
coli	NULL
competitor	NULL
DNA	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
;	NULL
compare	NULL
lane	NULL
2	NULL
with	NULL
3	NULL
and	NULL
lane	NULL
8	NULL
with	NULL
9	NULL
)	NULL
.	NULL

In	NULL
the	NULL
same	NULL
samples	NULL
,	NULL
the	NULL
competitor	NULL
DNA	NULL
completely	NULL
abrogated	NULL
matrix	NULL
binding	NULL
to	NULL
two	NULL
control	NULL
DNA	NULL
fragments	NULL
that	NULL
lack	NULL
MARs	NULL
,	NULL
the	NULL
plasmid	NULL
pUC19	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
a	NULL
fragment	NULL
derived	NULL
from	NULL
the	NULL
IgH	NULL
Cu	NULL
region	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

The	NULL
k	NULL
MAR	NULL
derived	NULL
from	NULL
the	NULL
Ig	NULL
light	NULL
chain	NULL
Â«	NULL
gene	NULL
J-C	NULL
intron	NULL
also	NULL
binds	NULL
to	NULL
the	NULL
nuclear	NULL
matrix	NULL
,	NULL
apparently	NULL
with	NULL
a	NULL
higher	NULL
binding	NULL
affinity	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
.	NULL

MARs	NULL
derived	NULL
from	NULL
a	NULL
Drosophila	NULL
histone	NULL
gene	NULL
(	NULL
Dr	NULL
MAR	NULL
)	NULL
and	NULL
from	NULL
an	NULL
IgH	NULL
chain	NULL
variable	NULL
region	NULL
gene	NULL
promoter	NULL
(	NULL
Webb	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
also	NULL
bind	NULL
to	NULL
these	NULL
nuclear	NULL
matrix	NULL
preparations	NULL
with	NULL
similar	NULL
binding	NULL
affinity	NULL
as	NULL
the	NULL
enhancer	NULL
MARs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
Soluble	NULL
Nuclear	NULL
Matrix	NULL
Protein	NULL
That	NULL
Binds	NULL
to	NULL
MAR	NULL
Sequences-In	NULL
order	NULL
to	NULL
further	NULL
characterize	NULL
this	NULL
matrix/	NULL
enhancer	NULL
interaction	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
a	NULL
MAR-binding	NULL
protein	NULL
isolated	NULL
from	NULL
nuclear	NULL
matrix	NULL
solubilized	NULL
in	NULL
8	NULL
M	NULL
urea	NULL
.	NULL

Total	NULL
soluble	NULL
nuclear	NULL
matrix	NULL
proteins	NULL
were	NULL
prepared	NULL
by	NULL
a	NULL
denaturation-renaturation	NULL
protocol	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Soluble	NULL
matrix	NULL
preparations	NULL
were	NULL
analyzed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
specific	NULL
MAR-binding	NULL
proteins	NULL
using	NULL
MSAs	NULL
.	NULL

Using	NULL
the	NULL
5'-En	NULL
MAR-containing	NULL
fragment	NULL
,	NULL
a	NULL
single	NULL
strong	NULL
protein-DNA	NULL
complex	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
generation	NULL
of	NULL
this	NULL
complex	NULL
could	NULL
be	NULL
competed	NULL
by	NULL
a	NULL
number	NULL
of	NULL
different	NULL
DNA	NULL
fragments	NULL
containing	NULL
MARs	NULL
,	NULL
the	NULL
5'-En	NULL
fragment	NULL
itself	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
MAR	NULL
Binding	NULL
and	NULL
IgH	NULL
Enhancer	NULL
Regulation	NULL
the	NULL
entire	NULL
1.0-kb	NULL
IgH	NULL
enhancer	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
,	NULL
3'-Ein	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
Dr	NULL
MAR	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
and	NULL
x	NULL
MAR	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
;	NULL
whereas	NULL
the	NULL
enhancer	NULL
core	NULL
fragment	NULL
could	NULL
not	NULL
compete	NULL
for	NULL
this	NULL
interaction	NULL
,	NULL
even	NULL
at	NULL
a	NULL
200-fold	NULL
molar	NULL
excess	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

This	NULL
interaction	NULL
is	NULL
not	NULL
simply	NULL
due	NULL
to	NULL
binding	NULL
of	NULL
DNA	NULL
that	NULL
has	NULL
an	NULL
A/T-rich	NULL
character	NULL
since	NULL
poly	NULL
(	NULL
dA/	NULL
dT	NULL
)	NULL
was	NULL
not	NULL
an	NULL
effective	NULL
competitor	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Using	NULL
the	NULL
3'-En	NULL
MAR-containing	NULL
fragment	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
a	NULL
similar	NULL
pattern	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Although	NULL
several	NULL
faint	NULL
complexes	NULL
were	NULL
observed	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
major	NULL
MAR-binding	NULL
complex	NULL
,	NULL
they	NULL
are	NULL
nonspecific	NULL
since	NULL
they	NULL
were	NULL
competed	NULL
by	NULL
the	NULL
enhancer	NULL
core	NULL
and	NULL
poly	NULL
(	NULL
dA/dT	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
same	NULL
MAR-binding	NULL
protein	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
complexes	NULL
seen	NULL
with	NULL
5'-En	NULL
and	NULL
3'-En	NULL
probes	NULL
,	NULL
and	NULL
yet	NULL
the	NULL
complex	NULL
formed	NULL
with	NULL
the	NULL
3'-En	NULL
fragment	NULL
migrates	NULL
more	NULL
slowly	NULL
than	NULL
the	NULL
5'-En	NULL
complex	NULL
.	NULL

This	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
ability	NULL
of	NULL
this	NULL
MAR-binding	NULL
protein	NULL
to	NULL
bend	NULL
the	NULL
bound	NULL
DNA	NULL
fragments	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Bending	NULL
tends	NULL
to	NULL
slow	NULL
the	NULL
mobility	NULL
of	NULL
protein-DNA	NULL
complexes	NULL
most	NULL
dramatically	NULL
when	NULL
the	NULL
binding	NULL
site	NULL
is	NULL
situated	NULL
in	NULL
the	NULL
center	NULL
of	NULL
the	NULL
fragment	NULL
(	NULL
Kim	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Perhaps	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
this	NULL
MAR-binding	NULL
protein	NULL
is	NULL
situated	NULL
in	NULL
the	NULL
middle	NULL
of	NULL
the	NULL
3'-En	NULL
fragment	NULL
but	NULL
close	NULL
to	NULL
one	NULL
of	NULL
the	NULL
ends	NULL
of	NULL
the	NULL
5'-En	NULL
fragment	NULL
.	NULL

Changes	NULL
in	NULL
mobility	NULL
of	NULL
bent	NULL
DNA	NULL
are	NULL
also	NULL
more	NULL
dramatic	NULL
with	NULL
smaller	NULL
DNA	NULL
fragments	NULL
.	NULL

Isolation	NULL
of	NULL
MAR-BP1-We	NULL
further	NULL
purified	NULL
this	NULL
MAR-binding	NULL
protein	NULL
from	NULL
other	NULL
soluble	NULL
nuclear	NULL
matrix	NULL
proteins	NULL
by	NULL
a	NULL
three-step	NULL
chromatography	NULL
procedure	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

The	NULL
protein	NULL
composition	NULL
of	NULL
different	NULL
purification	NULL
fractions	NULL
was	NULL
assessed	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
and	NULL
silver	NULL
staining	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

The	NULL
polypeptide	NULL
composition	NULL
of	NULL
the	NULL
total	NULL
nuclear	NULL
matrix	NULL
preparation	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
is	NULL
virtually	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
the	NULL
soluble	NULL
nuclear	NULL
matrix	NULL
preparation	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
renaturation	NULL
process	NULL
is	NULL
effective	NULL
at	NULL
the	NULL
solubilization	NULL
of	NULL
most	NULL
matrix	NULL
proteins	NULL
;	NULL
this	NULL
soluble	NULL
matrix	NULL
preparation	NULL
gives	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

The	NULL
amount	NULL
and	NULL
composition	NULL
of	NULL
proteins	NULL
in	NULL
the	NULL
denatured	NULL
pellet	NULL
is	NULL
variable	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
procedure	NULL
may	NULL
not	NULL
be	NULL
efficient	NULL
for	NULL
all	NULL
matrix	NULL
proteins	NULL
.	NULL

After	NULL
DNA-cellulose	NULL
affinity	NULL
chromatography	NULL
,	NULL
a	NULL
single	NULL
major	NULL
protein	NULL
can	NULL
be	NULL
identified	NULL
by	NULL
silver	NULL
staining	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
,	NULL
with	NULL
a	NULL
molecular	NULL
mass	NULL
of	NULL
~33	NULL
kDa	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
if	NULL
this	NULL
protein	NULL
is	NULL
indeed	NULL
responsible	NULL
for	NULL
MAR	NULL
binding	NULL
,	NULL
UV-cross-linking	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
determine	NULL
the	NULL
molecular	NULL
mass	NULL
of	NULL
the	NULL
MAR-binding	NULL
activity	NULL
present	NULL
in	NULL
this	NULL
purified	NULL
fraction	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
2	NULL
show	NULL
that	NULL
the	NULL
same	NULL
protein	NULL
binds	NULL
to	NULL
both	NULL
5'-En	NULL
and	NULL
3'-En	NULL
fragments	NULL
.	NULL

The	NULL
molecular	NULL
mass	NULL
of	NULL
this	NULL
labeled	NULL
species	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
33-kDa	NULL
protein	NULL
bound	NULL
to	NULL
a	NULL
small	NULL
stretch	NULL
of	NULL
DNA	NULL
predicted	NULL
to	NULL
remain	NULL
following	NULL
DNase	NULL
digestion	NULL
of	NULL
the	NULL
cross-linked	NULL
complex	NULL
.	NULL

Cross-linking	NULL
of	NULL
the	NULL
5'-En	NULL
fragment	NULL
with	NULL
purified	NULL
NF-uNR	NULL
gives	NULL
rise	NULL
to	NULL
a	NULL
larger	NULL
labeled	NULL
species	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
its	NULL
40-kDa	NULL
molecular	NULL
mass	NULL
(	NULL
Scheuermann	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

These	NULL
results	NULL
support	NULL
the	NULL
contention	NULL
that	NULL
although	NULL
these	NULL
binding	NULL
activities	NULL
interact	NULL
with	NULL
the	NULL
same	NULL
enhancer	NULL
fragments	NULL
,	NULL
they	NULL
are	NULL
distinct	NULL
.	NULL

We	NULL
have	NULL
named	NULL
this	NULL
MAR-binding	NULL
protein	NULL
,	NULL
MAR-BP1	NULL
,	NULL
for	NULL
matrix	NULL
attachment	NULL
region	NULL
binding	NULL
protein	NULL
1	NULL
.	NULL

The	NULL
cell	NULL
type	NULL
specificity	NULL
of	NULL
MAR-BP1	NULL
expression	NULL
was	NULL
investigated	NULL
by	NULL
evaluating	NULL
MAR	NULL
binding	NULL
activity	NULL
in	NULL
soluble	NULL
nuclear	NULL
matrix	NULL
preparations	NULL
isolated	NULL
from	NULL
preB	NULL
,	NULL
mature	NULL
B	NULL
,	NULL
and	NULL
mature	NULL
T	NULL
cell	NULL
lines	NULL
by	NULL
MSA	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

DNA	NULL
:	NULL
MAR-BP1	NULL
protein	NULL
complexes	NULL
were	NULL
found	NULL
using	NULL
soluble	NULL
matrix	NULL
preparations	NULL
from	NULL
all	NULL
six	NULL
cell	NULL
lines	NULL
tested	NULL
.	NULL

At	NULL
this	NULL
point	NULL
,	NULL
the	NULL
significance	NULL
of	NULL
lower	NULL
MAR-BP1	NULL
expression	NULL
in	NULL
preB	NULL
cell	NULL
lines	NULL
as	NULL
compared	NULL
with	NULL
mature	NULL
B	NULL
cell	NULL
lines	NULL
is	NULL
not	NULL
clear	NULL
,	NULL
but	NULL
it	NULL
is	NULL
a	NULL
consistent	NULL
finding	NULL
with	NULL
both	NULL
preB	NULL
cell	NULL
lines	NULL
examined	NULL
.	NULL

Analysis	NULL
of	NULL
MAR-BP1	NULL
Binding	NULL
Sites	NULL
in	NULL
the	NULL
IgH	NULL
Enhancer	NULL
Chemical	NULL
and	NULL
enzymatic	NULL
footprinting	NULL
approaches	NULL
are	NULL
fre-	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10Â°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
MAR	NULL
Binding	NULL
and	NULL
IgH	NULL
Enhancer	NULL
Regulation	NULL
A	NULL
M	NULL
NM	NULL
_	NULL
NM	NULL
SNM	NULL
DEAE	NULL
DCA	NULL
#	NULL
#	NULL
97kD	NULL
68kD	NULL
43kD	NULL
-	NULL
MARBP1	NULL
30KD	NULL
21kD	NULL
14kD	NULL
B	NULL
MARBP1	NULL
Controls	NULL
--	NULL
-c	NULL
c	NULL
c	NULL
â¬	NULL
wo	NULL
do	NULL
wi	NULL
0	NULL
w	NULL
[	NULL
te	NULL
]	NULL
i	NULL
in	NULL
in	NULL
el	NULL
106	NULL
80	NULL
49	NULL
-	NULL
#	NULL
144	NULL
<	NULL
4-	NULL
NENA	NULL
ï¬	NULL
Â«	NULL
-	NULL
MARBP	NULL
:	NULL
32	NULL
18	NULL
10	NULL
2	NULL
3	NULL
4	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Purification	NULL
of	NULL
a	NULL
soluble	NULL
MAR-binding	NULL
protein	NULL
.	NULL

A	NULL
,	NULL
purification	NULL
fractions	NULL
containing	NULL
MAR-binding	NULL
proteins	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
10	NULL
%	NULL
)	NULL
and	NULL
silver	NULL
staining	NULL
.	NULL

Lane	NULL
1	NULL
contains	NULL
silver	NULL
staining	NULL
marker	NULL
(	NULL
Bio-Rad	NULL
)	NULL
;	NULL
lane	NULL
2	NULL
contains	NULL
1	NULL
ug	NULL
of	NULL
the	NULL
nuclear	NULL
matrix	NULL
;	NULL
lame	NULL
3	NULL
contains	NULL
denatured	NULL
nuclear	NULL
matrix	NULL
pellet	NULL
;	NULL
lane	NULL
4	NULL
contains	NULL
1	NULL
ug	NULL
of	NULL
soluble	NULL
nuclear	NULL
matrix	NULL
protein	NULL
;	NULL
lane	NULL
5	NULL
contains	NULL
0.1	NULL
ug	NULL
of	NULL
the	NULL
DEAE	NULL
peak	NULL
fraction	NULL
;	NULL
lane	NULL
6	NULL
contains	NULL
10	NULL
ng	NULL
of	NULL
the	NULL
peak	NULL
fraction	NULL
from	NULL
DNA-cellulose	NULL
affinity	NULL
chromatography	NULL
.	NULL

B	NULL
,	NULL
UV	NULL
cross-linking	NULL
of	NULL
MAR-BP1	NULL
.	NULL

Internally	NULL
labeled	NULL
5'-En	NULL
(	NULL
Zanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
4	NULL
)	NULL
or	NULL
3'-En	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
fragments	NULL
were	NULL
used	NULL
in	NULL
MSAs	NULL
,	NULL
the	NULL
wet	NULL
gels	NULL
were	NULL
irradiated	NULL
,	NULL
specific	NULL
complexes	NULL
were	NULL
isolated	NULL
,	NULL
and	NULL
proteins	NULL
were	NULL
resolved	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Samples	NULL
for	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
contained	NULL
0.1	NULL
pg	NULL
of	NULL
MAR-BP1	NULL
DEAE	NULL
fraction	NULL
;	NULL
lame	NULL
3	NULL
contained	NULL
no	NULL
protein	NULL
;	NULL
lane	NULL
4	NULL
contained	NULL
10	NULL
ng	NULL
of	NULL
NF-pNR	NULL
fraction	NULL
Fiy	NULL
.	NULL

Molecular	NULL
masses	NULL
(	NULL
kDa	NULL
)	NULL
of	NULL
protein	NULL
size	NULL
markers	NULL
are	NULL
indicated	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
total	NULL
soluble	NULL
nuclear	NULL
extracts	NULL
and	NULL
DNA-cellulose	NULL
column	NULL
fractions	NULL
.	NULL

quently	NULL
used	NULL
to	NULL
identify	NULL
regions	NULL
of	NULL
DNA	NULL
that	NULL
are	NULL
physically	NULL
covered	NULL
by	NULL
the	NULL
interacting	NULL
protein	NULL
.	NULL

We	NULL
have	NULL
used	NULL
orthko-phe-nanthroline	NULL
copper	NULL
and	NULL
DNase	NULL
I	NULL
footprinting	NULL
and	NULL
missing	NULL
nucleoside	NULL
approaches	NULL
in	NULL
attempts	NULL
to	NULL
define	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
MAR-BP1	NULL
within	NULL
the	NULL
IgH	NULL
enhancer	NULL
without	NULL
success	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
soluble	NULL
nuclear	NULL
matrix	NULL
preparations	NULL
and	NULL
with	NULL
purified	NULL
MAR-BP1	NULL
under	NULL
conditions	NULL
where	NULL
>	NULL
80	NULL
%	NULL
of	NULL
the	NULL
DNA	NULL
was	NULL
bound	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
MSA	NULL
.	NULL

In	NULL
the	NULL
same	NULL
experiments	NULL
,	NULL
purified	NULL
NF-uNR	NULL
gave	NULL
strong	NULL
protected	NULL
regions	NULL
corresponding	NULL
to	NULL
the	NULL
binding	NULL
sites	NULL
described	NULL
previously	NULL
(	NULL
Scheuermann	NULL
and	NULL
Chen	NULL
,	NULL
1989	NULL
)	NULL
,	NULL
confirming	NULL
that	NULL
the	NULL
techniques	NULL
were	NULL
working	NULL
.	NULL

The	NULL
inability	NULL
to	NULL
identify	NULL
precise	NULL
binding	NULL
sites	NULL
for	NULL
other	NULL
MAR-binding	NULL
proteins	NULL
has	NULL
been	NULL
reported	NULL
(	NULL
e.g	NULL
.	NULL

Mielke	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
and	NULL
Tsutsui	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
SATB1	NULL
,	NULL
the	NULL
missing	NULL
nucleoside	NULL
approach	NULL
identified	NULL
binding	NULL
sites	NULL
,	NULL
while	NULL
DNase	NULL
and	NULL
chemical	NULL
footprinting	NULL
failed	NULL
(	NULL
Dickinson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

It	NULL
is	NULL
thought	NULL
that	NULL
MAR	NULL
binding	NULL
may	NULL
represent	NULL
the	NULL
combination	NULL
of	NULL
multiple	NULL
low	NULL
affinity	NULL
interactions	NULL
to	NULL
achieve	NULL
binding	NULL
specificity	NULL
,	NULL
since	NULL
the	NULL
binding	NULL
proteins	NULL
do	NULL
not	NULL
footprint	NULL
well	NULL
and	NULL
relatively	NULL
long	NULL
DNA	NULL
fragments	NULL
are	NULL
required	NULL
for	NULL
high	NULL
affinity	NULL
binding	NULL
.	NULL

This	NULL
may	NULL
also	NULL
be	NULL
the	NULL
case	NULL
for	NULL
MAR-BPL	NULL
.	NULL

Since	NULL
the	NULL
precise	NULL
mapping	NULL
of	NULL
MAR	NULL
sites	NULL
was	NULL
problematic	NULL
,	NULL
we	NULL
decided	NULL
to	NULL
concentrate	NULL
on	NULL
approaches	NULL
to	NULL
investigate	NULL
the	NULL
rela-	NULL
240183	NULL
J	NULL
Mature	NULL
B	NULL
cell	NULL
:	NULL
|	NULL
Pre-B	NULL
cell	NULL
J	NULL
T	NULL
cell	NULL
wWEHI1231	NULL
WEHI1279	NULL
PD31	NULL
70273	NULL
EL-4	NULL
BW5147	NULL
-p	NULL
US	NULL
Â«	NULL
-	NULL
==	NULL
bd	NULL
os	NULL
Free	NULL
probe	NULL
.	NULL

â	NULL
â	NULL
..	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Cell	NULL
type	NULL
distribution	NULL
of	NULL
MAR-BP1	NULL
.	NULL

Soluble	NULL
nuclear	NULL
matrix	NULL
proteins	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
different	NULL
cell	NULL
lines	NULL
as	NULL
indicated	NULL
.	NULL

MAR-BP1	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
examined	NULL
by	NULL
MSA	NULL
with	NULL
0.5	NULL
ug	NULL
of	NULL
protein	NULL
and	NULL
0.5	NULL
ng	NULL
of	NULL
5'-Ein	NULL
probe	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
characteristic	NULL
MAR-BP1	NULL
complex	NULL
.	NULL

tionships	NULL
between	NULL
NF-uNR	NULL
binding	NULL
sites	NULL
and	NULL
MAR-BP1	NULL
binding	NULL
using	NULL
MSAs	NULL
.	NULL

The	NULL
381-bp	NULL
5'-En	NULL
,	NULL
containing	NULL
the	NULL
NF-uNR	NULL
binding	NULL
sites	NULL
P1	NULL
and	NULL
P2	NULL
,	NULL
can	NULL
be	NULL
subdivided	NULL
into	NULL
smaller	NULL
fragments	NULL
by	NULL
restriction	NULL
enzyme	NULL
digestion	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

No	NULL
binding	NULL
could	NULL
be	NULL
demonstrated	NULL
with	NULL
purified	NULL
MAR-BP1	NULL
using	NULL
fragments	NULL
derived	NULL
from	NULL
either	NULL
end	NULL
of	NULL
the	NULL
5'-Ein	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
S-P	NULL
and	NULL
X-R	NULL
)	NULL
.	NULL

Specific	NULL
binding	NULL
could	NULL
be	NULL
demonstrated	NULL
to	NULL
a	NULL
subfragment	NULL
containing	NULL
the	NULL
middle	NULL
region	NULL
(	NULL
R-P	NULL
)	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
the	NULL
putative	NULL
MAR-BP1	NULL
binding	NULL
site	NULL
lies	NULL
within	NULL
the	NULL
185-bp	NULL
region	NULL
between	NULL
the	NULL
Rsal	NULL
and	NULL
the	NULL
SspI	NULL
sites	NULL
;	NULL
this	NULL
region	NULL
also	NULL
contains	NULL
the	NULL
NF-pNR	NULL
binding	NULL
sites	NULL
P1	NULL
and	NULL
P2	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
the	NULL
binding	NULL
affinity	NULL
for	NULL
this	NULL
subfragment	NULL
was	NULL
only	NULL
~20	NULL
%	NULL
of	NULL
that	NULL
of	NULL
the	NULL
whole	NULL
fragment	NULL
suggests	NULL
that	NULL
either	NULL
the	NULL
binding	NULL
site	NULL
had	NULL
been	NULL
partially	NULL
disrupted	NULL
by	NULL
restriction	NULL
enzyme	NULL
cleavage	NULL
or	NULL
that	NULL
the	NULL
length	NULL
requirement	NULL
for	NULL
high	NULL
affinity	NULL
binding	NULL
discussed	NULL
above	NULL
is	NULL
coming	NULL
into	NULL
play	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
experiments	NULL
using	NULL
3'-En	NULL
fragments	NULL
as	NULL
probes	NULL
,	NULL
i.e	NULL
.	NULL

only	NULL
the	NULL
whole	NULL
309-bp	NULL
fragment	NULL
had	NULL
MAR-BP1	NULL
binding	NULL
activ-ity	NULL
;	NULL
any	NULL
further	NULL
digestion	NULL
of	NULL
this	NULL
fragment	NULL
lead	NULL
to	NULL
a	NULL
dramatic	NULL
loss	NULL
of	NULL
binding	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
MAR-BP1	NULL
binds	NULL
to	NULL
both	NULL
the	NULL
3'-Fin	NULL
fragment	NULL
and	NULL
to	NULL
subfragments	NULL
of	NULL
5'-En	NULL
containing	NULL
NF-uNR	NULL
binding	NULL
sites	NULL
,	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
four	NULL
NF-uNR	NULL
sites	NULL
P1-P4	NULL
was	NULL
investigated	NULL
.	NULL

In	NULL
MSA	NULL
experiments	NULL
using	NULL
the	NULL
5'-En	NULL
fragment	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
IgH	NULL
enhancer	NULL
fragments	NULL
in	NULL
which	NULL
all	NULL
four	NULL
NF-pNR	NULL
binding	NULL
sites	NULL
had	NULL
been	NULL
deleted	NULL
were	NULL
considerable	NULL
less	NULL
effective	NULL
at	NULL
competition	NULL
than	NULL
the	NULL
wild-type	NULL
enhancer	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
deletion	NULL
of	NULL
either	NULL
P1	NULL
or	NULL
P2	NULL
from	NULL
the	NULL
5'-En	NULL
fragment	NULL
,	NULL
or	NULL
deletion	NULL
of	NULL
either	NULL
P3	NULL
or	NULL
P4	NULL
from	NULL
the	NULL
3'-En	NULL
fragment	NULL
significantly	NULL
reduced	NULL
their	NULL
ability	NULL
to	NULL
compete	NULL
with	NULL
the	NULL
respective	NULL
wild-type	NULL
fragments	NULL
for	NULL
MAR-BP1	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
NF-wNR	NULL
binding	NULL
sites	NULL
are	NULL
essential	NULL
for	NULL
MAR-BP1	NULL
binding	NULL
,	NULL
due	NULL
to	NULL
either	NULL
their	NULL
identity	NULL
or	NULL
extensive	NULL
overlap	NULL
.	NULL

To	NULL
further	NULL
analyze	NULL
the	NULL
influence	NULL
of	NULL
NF-uNR	NULL
sites	NULL
on	NULL
MARBP1	NULL
binding	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
DNA	NULL
binding	NULL
affinity	NULL
using	NULL
5'-En	NULL
fragments	NULL
with	NULL
or	NULL
without	NULL
either	NULL
P1	NULL
or	NULL
P2	NULL
site	NULL
deletion	NULL
(	NULL
Fig	NULL
.	NULL

56	NULL
)	NULL
.	NULL

The	NULL
calculated	NULL
dissociation	NULL
(	NULL
K.	NULL
;	NULL
)	NULL
constant	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
intact	NULL
5-En	NULL
fragment	NULL
is	NULL
1.5	NULL
X	NULL
10~Â®	NULL
m.	NULL
However	NULL
deletion	NULL
of	NULL
either	NULL
P1	NULL
or	NULL
P2	NULL
site	NULL
dramatically	NULL
decreases	NULL
the	NULL
MAR-binding	NULL
affinity	NULL
by	NULL
a	NULL
factor	NULL
of	NULL
5	NULL
or	NULL
more	NULL
.	NULL

This	NULL
reduction	NULL
in	NULL
affinity	NULL
is	NULL
not	NULL
simply	NULL
due	NULL
to	NULL
a	NULL
shortening	NULL
of	NULL
the	NULL
DNA	NULL
probe	NULL
size	NULL
,	NULL
since	NULL
removal	NULL
of	NULL
80	NULL
bp	NULL
from	NULL
the	NULL
5	NULL
'	NULL
end	NULL
by	NULL
MbolI	NULL
digestion	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
binding	NULL
affinity	NULL
.	NULL

Taken	NULL
together	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
NF-pNR	NULL
binding	NULL
sites	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
for	NULL
MAR-BP1	NULL
binding	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10Â°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
24014	NULL
MAR	NULL
Binding	NULL
and	NULL
IgH	NULL
Enhancer	NULL
Regulation	NULL
A	NULL
D	NULL
C	NULL
ut	NULL
Xbal	NULL
Rsal	NULL
Sspl	NULL
Pvull	NULL
L	NULL
ip	NULL
_	NULL
.	NULL

-m	NULL
ts	NULL
1	NULL
xp	NULL
&	NULL
#	NULL
$	NULL
_	NULL
Â§	NULL
Pj	NULL
po	NULL
(	NULL
881	NULL
bp	NULL
}	NULL
â¬	NULL
T	NULL
i106	NULL
3	NULL
e	NULL
Â§	NULL
a	NULL
a	NULL
|	NULL
g	NULL
f	NULL
Â§	NULL
w	NULL
a	NULL
Asal	NULL
Pvull	NULL
9	NULL
t	NULL
i	NULL
im	NULL
t	NULL
g	NULL
4	NULL
9	NULL
m	NULL
a	NULL
C	NULL
RP	NULL
.	NULL

a	NULL
s	NULL
no	NULL
a	NULL
WoL	NULL
s	NULL
s	NULL
mos	NULL
@	NULL
-B	NULL
--	NULL
--	NULL
--	NULL
EK	NULL
--	NULL
--	NULL
_-_-	NULL
Competitor	NULL
Z	NULL
2	NULL
u	NULL
u	NULL
i	NULL
p	NULL
2	NULL
2	NULL
t	NULL
1	NULL
a	NULL
Pi	NULL
p2	NULL
(	NULL
225	NULL
bp	NULL
)	NULL
Xbal	NULL
I	NULL
teat	NULL
soe	NULL
ted	NULL
ss	NULL
G-Real	NULL
xn	NULL
-+	NULL
_	NULL
Â©0000	NULL
c-	NULL
as	NULL
(	NULL
156	NULL
bp	NULL
)	NULL
Sspi	NULL
Puull	NULL
Free	NULL
probe	NULL
se	NULL
0	NULL
--	NULL
us	NULL
as	NULL
0	NULL
as	NULL
Pzh	NULL
(	NULL
70	NULL
bp	NULL
)	NULL
F	NULL
tng	NULL
ant	NULL
tas	NULL
``	NULL
*C	NULL
B	NULL
1	NULL
2	NULL
8	NULL
4	NULL
5	NULL
60	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
100	NULL
E	NULL
70	NULL
a-fg	NULL
60	NULL
Â£	NULL
2	NULL
4	NULL
50h	NULL
G	NULL
Â®	NULL
wts	NULL
Â£	NULL
T6	NULL
2	NULL
I	NULL
-	NULL
ad	NULL
hed	NULL
C	NULL
7	NULL
o	NULL
.	NULL

4	NULL
2	NULL
A	NULL
3	NULL
+s	NULL
a	NULL
30	NULL
{	NULL
PJ	NULL
<	NULL
==	NULL
s	NULL
20	NULL
7	NULL
[	NULL
=	NULL
20	NULL
-	NULL
O	NULL
&	NULL
'En	NULL
Â®	NULL
Mboll	NULL
5	NULL
%	NULL
En	NULL
ai	NULL
10	NULL
-	NULL
Â®	NULL
di-5'En	NULL
5-P	NULL
x-R	NULL
R-P	NULL
x-P	NULL
O	NULL
a2-5'En	NULL
0	NULL
DNA	NULL
fragment	NULL
1	NULL
10	NULL
100	NULL
C	NULL
MAR-BP1	NULL
conc	NULL
.	NULL

X	NULL
10Â°	NULL
(	NULL
M	NULL
)	NULL
Competitor	NULL
mut	NULL
IgHE	NULL
wt	NULL
IgHE	NULL
[	NULL
OO	NULL
CAT	NULL
CTO	NULL
(	NULL
molar	NULL
excess	NULL
)	NULL
10	NULL
50100	NULL
10	NULL
50	NULL
100	NULL
*	NULL
_-	NULL
00086	NULL
-	NULL
--	NULL
Free	NULL
probe	NULL
â	NULL
-	NULL
..-	NULL
â	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

MAR-BP1	NULL
binding	NULL
requires	NULL
NF-uNR	NULL
sites	NULL
.	NULL

A	NULL
,	NULL
381-bp	NULL
5-En	NULL
fragment	NULL
(	NULL
X-P	NULL
)	NULL
was	NULL
digested	NULL
with	NULL
restriction	NULL
enzymes	NULL
and	NULL
subfragments	NULL
isolated	NULL
as	NULL
indicated	NULL
.	NULL

B	NULL
,	NULL
MAR-BP1	NULL
binding	NULL
to	NULL
the	NULL
probes	NULL
described	NULL
in	NULL
A	NULL
was	NULL
evaluated	NULL
by	NULL
MSA	NULL
,	NULL
quantified	NULL
by	NULL
PhosphorImaging	NULL
,	NULL
and	NULL
plotted	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
total	NULL
probe	NULL
in	NULL
the	NULL
reaction	NULL
mix	NULL
.	NULL

C	NULL
,	NULL
different	NULL
NF-uNR	NULL
binding	NULL
site	NULL
deletion	NULL
mutants	NULL
were	NULL
used	NULL
in	NULL
MSA	NULL
competition	NULL
experiments	NULL
to	NULL
test	NULL
the	NULL
effect	NULL
of	NULL
NF-u.NR	NULL
binding	NULL
sites	NULL
on	NULL
MAR-BP1	NULL
binding	NULL
.	NULL

*Â°P-labeled	NULL
5'-Ein	NULL
was	NULL
incubated	NULL
with	NULL
5	NULL
ul	NULL
of	NULL
MAR-BP1	NULL
DEAE	NULL
fraction	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
10-100	NULL
fold	NULL
molar	NULL
excess	NULL
of	NULL
competitor	NULL
DNA	NULL
from	NULL
wild-type	NULL
or	NULL
mutant	NULL
IgH	NULL
enhancer	NULL
containing	NULL
deletions	NULL
of	NULL
NF-uNR	NULL
binding	NULL
sites	NULL
P1	NULL
,	NULL
P2	NULL
,	NULL
P3	NULL
,	NULL
and	NULL
P4	NULL
(	NULL
mut	NULL
)	NULL
.	NULL

D	NULL
,	NULL
wild-type	NULL
,	NULL
P1	NULL
,	NULL
or	NULL
P2	NULL
deletion	NULL
mutant	NULL
(	NULL
d1-5'En	NULL
and	NULL
d2-5'En	NULL
)	NULL
5'-En	NULL
DNAs	NULL
were	NULL
used	NULL
as	NULL
competitors	NULL
at	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
in	NULL
binding	NULL
reactions	NULL
containing	NULL
labeled	NULL
5'-En	NULL
probe	NULL
(	NULL
lanes	NULL
1-6	NULL
)	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Wild-type	NULL
,	NULL
P3	NULL
,	NULL
or	NULL
P4	NULL
deletion	NULL
mutants	NULL
were	NULL
used	NULL
in	NULL
competition	NULL
experiment	NULL
containing	NULL
labeled	NULL
3'-En	NULL
probe	NULL
(	NULL
Fares	NULL
7-11	NULL
)	NULL
.	NULL

E	NULL
,	NULL
binding	NULL
affinities	NULL
of	NULL
MAR-BP1	NULL
to	NULL
wild-type	NULL
or	NULL
mutant	NULL
5'-En	NULL
fragments	NULL
.	NULL

Binding	NULL
of	NULL
varying	NULL
concentrations	NULL
of	NULL
MAR-BP1	NULL
to	NULL
DNA	NULL
probes	NULL
(	NULL
25	NULL
pM	NULL
)	NULL
was	NULL
measured	NULL
by	NULL
MSA	NULL
.	NULL

The	NULL
DNA	NULL
probes	NULL
included	NULL
the	NULL
381-bp	NULL
5'-En	NULL
fragment	NULL
(	NULL
open	NULL
squares	NULL
)	NULL
,	NULL
the	NULL
301-bp	NULL
Mboll	NULL
5'-En	NULL
fragment	NULL
(	NULL
closed	NULL
squares	NULL
)	NULL
,	NULL
the	NULL
350-bp	NULL
d1-5'En	NULL
fragment	NULL
(	NULL
closed	NULL
circles	NULL
)	NULL
,	NULL
and	NULL
the	NULL
330-bp	NULL
d2-5'En	NULL
fragment	NULL
(	NULL
open	NULL
circles	NULL
)	NULL
.	NULL

The	NULL
dissociation	NULL
constant	NULL
(	NULL
K	NULL
,	NULL
,	NULL
)	NULL
was	NULL
calculated	NULL
from	NULL
the	NULL
protein	NULL
concentration	NULL
required	NULL
for	NULL
a	NULL
50	NULL
%	NULL
shift	NULL
of	NULL
the	NULL
probe	NULL
(	NULL
Koudelka	NULL
,	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Dickinson	NULL
and	NULL
Kohwi-Shigematsu	NULL
,	NULL
1995	NULL
)	NULL
to	NULL
be	NULL
1.5	NULL
x	NULL
10~Â®	NULL
M	NULL
for	NULL
both	NULL
the	NULL
5'-En	NULL
and	NULL
the	NULL
Mboll	NULL
5'-En	NULL
fragments	NULL
.	NULL

The	NULL
affinities	NULL
for	NULL
the	NULL
d1-5'En	NULL
and	NULL
d2-5'En	NULL
fragments	NULL
were	NULL
estimated	NULL
to	NULL
be	NULL
at	NULL
least	NULL
5-fold	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
the	NULL
wild-type	NULL
5'En	NULL
fragment	NULL
based	NULL
on	NULL
the	NULL
relative	NULL
amounts	NULL
of	NULL
protein	NULL
needed	NULL
to	NULL
bind	NULL
10	NULL
%	NULL
of	NULL
the	NULL
respective	NULL
probes	NULL
.	NULL

A	NULL
comparison	NULL
of	NULL
the	NULL
binding	NULL
affinities	NULL
for	NULL
MAR-BP1	NULL
and	NULL
other	NULL
DNA-binding	NULL
proteins	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
indicates	NULL
that	NULL
although	NULL
the	NULL
affinity	NULL
of	NULL
MAR-BP1	NULL
for	NULL
MAR	NULL
fragments	NULL
is	NULL
lower	NULL
than	NULL
that	NULL
measured	NULL
for	NULL
several	NULL
transcriptional	NULL
regulatory	NULL
proteins	NULL
like	NULL
NF-uNR	NULL
,	NULL
LEF-HMG	NULL
,	NULL
SP1	NULL
,	NULL
and	NULL
MLTF	NULL
,	NULL
it	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
affinity	NULL
measured	NULL
for	NULL
another	NULL
MAR-binding	NULL
protein	NULL
,	NULL
nucleolin	NULL
.	NULL

Binding	NULL
of	NULL
the	NULL
Nuclear	NULL
Matrix	NULL
or	NULL
MAR-BP1	NULL
and	NULL
NF-uNR	NULL
to	NULL
the	NULL
IgH	NULL
Enhancer	NULL
Is	NULL
Mutually	NULL
Exclusive-We	NULL
have	NULL
proposed	NULL
a	NULL
model	NULL
for	NULL
NF-puNR	NULL
function	NULL
in	NULL
which	NULL
binding	NULL
of	NULL
NF-pNR	NULL
to	NULL
its	NULL
four	NULL
sites	NULL
flanking	NULL
the	NULL
IgH	NULL
enhancer	NULL
would	NULL
repress	NULL
enhancer	NULL
function	NULL
by	NULL
preventing	NULL
nuclear	NULL
matrix	NULL
attachment	NULL
.	NULL

This	NULL
model	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
observed	NULL
requirement	NULL
for	NULL
NF-uNR	NULL
sites	NULL
for	NULL
MAR-BP1	NULL
binding	NULL
.	NULL

To	NULL
further	NULL
address	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
NF-uNR	NULL
binding	NULL
on	NULL
the	NULL
association	NULL
of	NULL
the	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10Â°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
MAR	NULL
Binding	NULL
and	NULL
IgH	NULL
Enhancer	NULL
Regulation	NULL
24015	NULL
TaBtE	NULL
I	NULL
Binding	NULL
affinities	NULL
of	NULL
MAR-BP1	NULL
and	NULL
other	NULL
DNA-binding	NULL
proteins	NULL
Protein	NULL
K	NULL
,	NULL
References	NULL
10~Â°	NULL
m	NULL
MAR-BPL	NULL
15	NULL
This	NULL
study	NULL
Nucleolin	NULL
5-24	NULL
Dickinson	NULL
and	NULL
Kohwi-Shigematsu	NULL
(	NULL
1995	NULL
)	NULL
SATBL	NULL
0.1-1.0	NULL
Dickinson	NULL
and	NULL
Kohwi-Shigematsu	NULL
(	NULL
1995	NULL
)	NULL
NF-uNR	NULL
0.063-8.3	NULL
Scheuermann	NULL
(	NULL
1992	NULL
)	NULL
LEF-HMG	NULL
1.0	NULL
Giese	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
SP1	NULL
1.9-2.4	NULL
Letovsky	NULL
and	NULL
Dynan	NULL
(	NULL
1989	NULL
)	NULL
MLTF	NULL
0.0025-0.1	NULL
Chodosh	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
IgH	NULL
enhancer	NULL
with	NULL
the	NULL
nuclear	NULL
matrix	NULL
in	NULL
vitro	NULL
.	NULL

Purified	NULL
NF-NR	NULL
was	NULL
preincubated	NULL
with	NULL
the	NULL
IgH	NULL
enhancer	NULL
followed	NULL
by	NULL
binding	NULL
analysis	NULL
to	NULL
insoluble	NULL
nuclear	NULL
matrix	NULL
preparations	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
.	NULL

Binding	NULL
of	NULL
NF-uNR	NULL
to	NULL
the	NULL
IgH	NULL
enhancer	NULL
prevents	NULL
its	NULL
interaction	NULL
with	NULL
the	NULL
nuclear	NULL
matrix	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
,	NULL
in	NULL
support	NULL
of	NULL
this	NULL
model	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
neither	NULL
total	NULL
soluble	NULL
nuclear	NULL
matrix	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
nor	NULL
purified	NULL
MAR-BPL	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
was	NULL
found	NULL
to	NULL
inhibit	NULL
binding	NULL
of	NULL
the	NULL
enhancer	NULL
to	NULL
insoluble	NULL
nuclear	NULL
matrix	NULL
;	NULL
rather	NULL
,	NULL
stimulation	NULL
of	NULL
binding	NULL
was	NULL
observed	NULL
.	NULL

This	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
ability	NULL
of	NULL
soluble	NULL
matrix	NULL
proteins	NULL
like	NULL
MARBP1	NULL
to	NULL
bind	NULL
insoluble	NULL
matrix	NULL
through	NULL
protein-protein	NULL
interac-tions	NULL
,	NULL
bringing	NULL
down	NULL
additional	NULL
enhancer	NULL
DNA	NULL
.	NULL

The	NULL
requirement	NULL
of	NULL
NF-uNR	NULL
sites	NULL
for	NULL
MAR-BP1	NULL
binding	NULL
suggests	NULL
that	NULL
the	NULL
interaction	NULL
of	NULL
these	NULL
two	NULL
proteins	NULL
might	NULL
be	NULL
mutually	NULL
exclusive	NULL
.	NULL

To	NULL
address	NULL
this	NULL
possibility	NULL
,	NULL
a	NULL
kinetic	NULL
experiment	NULL
was	NULL
performed	NULL
to	NULL
examine	NULL
NF-uNR	NULL
binding	NULL
to	NULL
a	NULL
mixture	NULL
of	NULL
free	NULL
DNA	NULL
and	NULL
DNA-MAR-BP1	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

With	NULL
time	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
NF-uNRDNA	NULL
complex	NULL
increases	NULL
until	NULL
equilibrium	NULL
is	NULL
reached	NULL
(	NULL
by	NULL
~15	NULL
min	NULL
)	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
NF-uNRDNA	NULL
complex	NULL
is	NULL
balanced	NULL
by	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
free	NULL
probe	NULL
remaining	NULL
(	NULL
Zanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
MAR-BPI-DNA	NULL
complex	NULL
remains	NULL
unchanged	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
MAR-BP1	NULL
binding	NULL
prevents	NULL
NF-uNR	NULL
interaction	NULL
.	NULL

However	NULL
,	NULL
if	NULL
excess	NULL
NF-uNR	NULL
is	NULL
used	NULL
and	NULL
the	NULL
reaction	NULL
is	NULL
allowed	NULL
to	NULL
proceed	NULL
for	NULL
60	NULL
min	NULL
,	NULL
well	NULL
beyond	NULL
the	NULL
half-life	NULL
of	NULL
the	NULL
MAR-BPI-DNA	NULL
complex	NULL
(	NULL
25	NULL
min	NULL
)	NULL
,	NULL
NF-uNR	NULL
will	NULL
replace	NULL
MAR-BPL	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

This	NULL
result	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
higher	NULL
affinity	NULL
of	NULL
NF-uNR	NULL
for	NULL
this	NULL
fragment	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
cells	NULL
where	NULL
both	NULL
NF-uNR	NULL
and	NULL
MAR-BP1	NULL
are	NULL
present	NULL
(	NULL
e.g	NULL
.	NULL

non-B	NULL
cells	NULL
)	NULL
the	NULL
enhancer	NULL
would	NULL
be	NULL
occupied	NULL
by	NULL
NF-uNR	NULL
.	NULL

DISCUSSION	NULL
MAR-BP1	NULL
Is	NULL
a	NULL
Novel	NULL
Nuclear	NULL
Matrix-derived	NULL
MAR	NULL
Binding	NULL
Protein-MAR-BP1	NULL
was	NULL
isolated	NULL
from	NULL
nuclear	NULL
matrix	NULL
samples	NULL
prepared	NULL
by	NULL
the	NULL
high	NULL
salt	NULL
method	NULL
from	NULL
a	NULL
mature	NULL
B	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
migrates	NULL
as	NULL
a	NULL
33-kDa	NULL
protein	NULL
on	NULL
SDS-polyacrylamide	NULL
gels	NULL
.	NULL

The	NULL
question	NULL
arises	NULL
as	NULL
to	NULL
the	NULL
relationship	NULL
between	NULL
MAR-BP1	NULL
and	NULL
other	NULL
identified	NULL
nuclear	NULL
matrix	NULL
proteins	NULL
.	NULL

In	NULL
one	NULL
study	NULL
,	NULL
the	NULL
protein	NULL
composition	NULL
of	NULL
a	NULL
highly	NULL
purified	NULL
nuclear	NULL
matrix	NULL
preparation	NULL
from	NULL
rat	NULL
liver	NULL
contained	NULL
12	NULL
major	NULL
proteins	NULL
including	NULL
lamins	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
,	NULL
the	NULL
B-23	NULL
nucleolar	NULL
protein	NULL
,	NULL
an	NULL
hnRNP	NULL
protein	NULL
,	NULL
and	NULL
eight	NULL
other	NULL
unidentified	NULL
proteins	NULL
termed	NULL
nuclear	NULL
matrins	NULL
(	NULL
Hakes	NULL
and	NULL
Berezney	NULL
,	NULL
1991	NULL
;	NULL
Berezney	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
these	NULL
major	NULL
proteins	NULL
,	NULL
a	NULL
number	NULL
of	NULL
minor	NULL
proteins	NULL
have	NULL
also	NULL
been	NULL
purified	NULL
from	NULL
the	NULL
nuclear	NULL
matrix	NULL
.	NULL

Many	NULL
of	NULL
these	NULL
proteins	NULL
appear	NULL
to	NULL
be	NULL
cell-type	NULL
specific	NULL
(	NULL
Fey	NULL
and	NULL
Penman	NULL
,	NULL
1988	NULL
)	NULL
.	NULL

A	NULL
group	NULL
of	NULL
proteins	NULL
have	NULL
been	NULL
identified	NULL
that	NULL
bind	NULL
to	NULL
MARs	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
67-kDa	NULL
lamin	NULL
B1	NULL
has	NULL
been	NULL
found	NULL
to	NULL
bind	NULL
MAR	NULL
sites	NULL
(	NULL
Luderus	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
116-kDa	NULL
yeast	NULL
protein	NULL
RAP-1	NULL
binds	NULL
to	NULL
the	NULL
silent	NULL
mating-type	NULL
locus	NULL
in	NULL
the	NULL
region	NULL
of	NULL
the	NULL
transcriptional	NULL
silencer	NULL
(	NULL
Hofmann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
95-kDa	NULL
protein	NULL
ARBP	NULL
was	NULL
isolated	NULL
based	NULL
on	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
to	NULL
MARs	NULL
from	NULL
the	NULL
chicken	NULL
lysozyme	NULL
gene	NULL
and	NULL
was	NULL
found	NULL
to	NULL
bind	NULL
the	NULL
IgH	NULL
enhancer	NULL
MAR	NULL
as	NULL
well	NULL
(	NULL
von	NULL
Kries	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

SAF-A/	NULL
hnRNP-U	NULL
,	NULL
a	NULL
120-kDa	NULL
protein	NULL
isolated	NULL
from	NULL
HeLa	NULL
cells	NULL
,	NULL
binds	NULL
to	NULL
A	NULL
IP	NULL
+	NULL
+	NULL
+	NULL
Competitor	NULL
(	NULL
0.2	NULL
pg/pl	NULL
)	NULL
IP	NULL
-	NULL
+	NULL
+	NULL
NF-uNR	NULL
(	NULL
200	NULL
ng/m	NULL
!	NULL
)	NULL

aD	NULL
-	NULL
4	NULL
u1.2	NULL
&	NULL
a	NULL
*	NULL
C-	NULL
IgHhE	NULL
1	NULL
2	NULL
3	NULL
4	NULL
B	NULL
LP	NULL
4	NULL
+	NULL
+	NULL
Competitor	NULL
(	NULL
0.2g9/ul	NULL
)	NULL
IP	NULL
=	NULL
+	NULL
+	NULL
MAR-binding	NULL
protein	NULL
-	NULL
ag-	NULL
-	NULL
p1.2	NULL
UD	NULL
--	NULL
wo	NULL
th	NULL
<	NULL
-	NULL
008	NULL
:	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

NF-uNR	NULL
inhibits	NULL
nuclear	NULL
matrix/enhancer	NULL
interaction	NULL
.	NULL

A	NULL
,	NULL
Â°P-labeled	NULL
IgH	NULL
enhancer	NULL
and	NULL
the	NULL
Cu	NULL
control	NULL
fragments	NULL
were	NULL
analyzed	NULL
for	NULL
specific	NULL
binding	NULL
to	NULL
insoluble	NULL
nuclear	NULL
matrix	NULL
preparation	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
(	NULL
Zanes	NULL
2-4	NULL
)	NULL
.	NULL

For	NULL
samples	NULL
in	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
,	NULL
NF-uNR	NULL
(	NULL
20	NULL
ng	NULL
)	NULL
was	NULL
preincubated	NULL
with	NULL
the	NULL
DNA	NULL
for	NULL
30	NULL
min	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
insoluble	NULL
nuclear	NULL
matrix	NULL
.	NULL

Lane	NULL
1	NULL
contains	NULL
input	NULL
DNA	NULL
(	NULL
25	NULL
%	NULL
)	NULL
.	NULL

B	NULL
,	NULL
the	NULL
experiment	NULL
was	NULL
performed	NULL
as	NULL
in	NULL
A	NULL
except	NULL
that	NULL
either	NULL
0.2	NULL
ug	NULL
of	NULL
total	NULL
soluble	NULL
nuclear	NULL
matrix	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
or	NULL
50	NULL
ng	NULL
of	NULL
purified	NULL
MAR-BP1	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
was	NULL
used	NULL
in	NULL
place	NULL
of	NULL
NF-uNKR	NULL
.	NULL

Time	NULL
(	NULL
min	NULL
)	NULL
-	NULL
0	NULL
3	NULL
5	NULL
1015	NULL
20	NULL
L.	NULL
wo	NULL
Â®	NULL
w	NULL
is	NULL
-	NULL
#	NULL
tai	NULL
#	NULL
4	NULL
me	NULL
maARGP1-	NULL
Â»	NULL
_	NULL
bus	NULL
bo	NULL
#	NULL
#	NULL
Â»	NULL
Â«	NULL
#	NULL
wil	NULL
y	NULL
Â«	NULL
Free	NULL
probe	NULL
u	NULL
.	NULL

1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

MAR-BP1	NULL
prevents	NULL
binding	NULL
of	NULL
NF-uNR	NULL
to	NULL
the	NULL
5'-En	NULL
fragment	NULL
.	NULL

MAR-BP1	NULL
(	NULL
DEAE	NULL
fraction	NULL
,	NULL
20	NULL
ng	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
labeled	NULL
5-En	NULL
fragment	NULL
for	NULL
30	NULL
min	NULL
to	NULL
reach	NULL
equilibrium	NULL
.	NULL

NF-uNR	NULL
(	NULL
2	NULL
ng	NULL
)	NULL
was	NULL
then	NULL
added	NULL
to	NULL
each	NULL
reaction	NULL
,	NULL
and	NULL
samples	NULL
were	NULL
loaded	NULL
onto	NULL
an	NULL
MSA	NULL
ge	NULL
!	NULL

at	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

a	NULL
scaffold	NULL
attachment	NULL
region	NULL
element	NULL
from	NULL
the	NULL
topoisomerase	NULL
I	NULL
gene	NULL
(	NULL
Romig	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Fackelmayer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

was	NULL
cloned	NULL
as	NULL
a	NULL
gene	NULL
encoding	NULL
a	NULL
thymus-specific	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
an	NULL
A/T-rich	NULL
motif	NULL
found	NULL
in	NULL
many	NULL
MARs	NULL
,	NULL
including	NULL
those	NULL
flanking	NULL
the	NULL
IgH	NULL
enhancer	NULL
(	NULL
Dickinson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

While	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
cloned	NULL
SATB1	NULL
gene	NULL
predicts	NULL
a	NULL
molecular	NULL
mass	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10Â°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
24016	NULL
To	NULL
lq	NULL
ue	NULL
-~	NULL
_	NULL
NF-pNR	NULL
u	NULL
Eo	NULL
,	NULL
MAR-BP1	NULL
+/+	NULL
va	NULL
bi	NULL
b	NULL
0D	NULL
_	NULL
<	NULL
-	NULL
a	NULL
to	NULL
as	NULL
td	NULL
td	NULL
ast	NULL
wo	NULL
=	NULL
>	NULL
~*	NULL
<	NULL
4-	NULL
B	NULL
â	NULL
it-o	NULL
.	NULL

1Â°	NULL
20	NULL
3	NULL
4	NULL
50	NULL
60	NULL
7	NULL
8	NULL
9	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

NF-uNR	NULL
displaces	NULL
DNA-bound	NULL
MAR-BPI	NULL
.	NULL

MAR-BPI	NULL
DEAE	NULL
fraction	NULL
(	NULL
20	NULL
ng	NULL
,	NULL
lane	NULL
2	NULL
;	NULL
25	NULL
ng	NULL
,	NULL
lane	NULL
3	NULL
;	NULL
30	NULL
ng	NULL
,	NULL
lane	NULL
4	NULL
;	NULL
40	NULL
ng	NULL
,	NULL
lanes	NULL
5-9	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
labeled	NULL
5'-En	NULL
fragment	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
to	NULL
reach	NULL
equilibrium	NULL
,	NULL
at	NULL
which	NULL
time	NULL
purified	NULL
NF-uNR	NULL
was	NULL
added	NULL
at	NULL
2	NULL
ng	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
3	NULL
ng	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
3.5	NULL
ng	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
and	NULL
4	NULL
ng	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

Incubation	NULL
was	NULL
continued	NULL
for	NULL
an	NULL
additional	NULL
60	NULL
min	NULL
on	NULL
ice	NULL
before	NULL
MSA	NULL
analysis	NULL
.	NULL

m	NULL
wad	NULL
*	NULL
Free	NULL
probe	NULL
of	NULL
86,000	NULL
,	NULL
the	NULL
protein	NULL
migrates	NULL
to	NULL
a	NULL
position	NULL
of	NULL
~103,000	NULL
in	NULL
SDS/polyacrylamide	NULL
gels	NULL
even	NULL
when	NULL
translated	NULL
in	NULL
vitro	NULL
(	NULL
Nak-agomi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
its	NULL
size	NULL
,	NULL
MAR-BP1	NULL
is	NULL
distinct	NULL
from	NULL
these	NULL
members	NULL
of	NULL
the	NULL
MAR-binding	NULL
family	NULL
of	NULL
nuclear	NULL
proteins	NULL
.	NULL

However	NULL
,	NULL
two	NULL
proteins	NULL
that	NULL
have	NULL
been	NULL
found	NULL
to	NULL
bind	NULL
MARs	NULL
have	NULL
similar	NULL
sizes	NULL
,	NULL
NF-uNR	NULL
and	NULL
histone	NULL
HL	NULL
.	NULL

A	NULL
variety	NULL
of	NULL
observations	NULL
presented	NULL
here	NULL
indicate	NULL
that	NULL
MAR-BP1	NULL
and	NULL
NF-pNR	NULL
are	NULL
distinct	NULL
.	NULL

Complexes	NULL
formed	NULL
by	NULL
NF-uNR	NULL
and	NULL
DNA	NULL
containing	NULL
its	NULL
recognition	NULL
sites	NULL
form	NULL
characteristic	NULL
complexes	NULL
that	NULL
migrate	NULL
very	NULL
slowly	NULL
in	NULL
MSA	NULL
gels	NULL
.	NULL

Complexes	NULL
with	NULL
MAR-BP1	NULL
migrate	NULL
more	NULL
rapidly	NULL
.	NULL

NF-uNR	NULL
binding	NULL
generates	NULL
complexes	NULL
that	NULL
are	NULL
easily	NULL
analyzed	NULL
by	NULL
DNase	NULL
I	NULL
footprinting	NULL
,	NULL
whereas	NULL
MAR-BP1	NULL
complexes	NULL
are	NULL
not	NULL
.	NULL

The	NULL
most	NULL
convincing	NULL
argument	NULL
that	NULL
they	NULL
are	NULL
distinct	NULL
is	NULL
that	NULL
UV-cross-linking	NULL
reveals	NULL
proteins	NULL
of	NULL
different	NULL
sizes	NULL
.	NULL

MAR-BP1	NULL
also	NULL
appears	NULL
to	NULL
be	NULL
distinct	NULL
from	NULL
histone	NULL
H1	NULL
.	NULL

Purified	NULL
histone	NULL
H1	NULL
from	NULL
the	NULL
same	NULL
B	NULL
cell	NULL
line	NULL
has	NULL
different	NULL
DNA-binding/competition	NULL
characteristic	NULL
and	NULL
antigenicity	NULL
as	NULL
compared	NULL
with	NULL
MAR-BP1.2	NULL
Our	NULL
results	NULL
describe	NULL
the	NULL
identification	NULL
of	NULL
a	NULL
novel	NULL
MAR-binding	NULL
protein	NULL
that	NULL
specifically	NULL
binds	NULL
to	NULL
MAR	NULL
sites	NULL
associated	NULL
with	NULL
the	NULL
IgH	NULL
intronic	NULL
enhancer	NULL
.	NULL

Although	NULL
we	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
other	NULL
matrix	NULL
proteins	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
association	NULL
between	NULL
the	NULL
nuclear	NULL
matrix	NULL
and	NULL
the	NULL
IgH	NULL
enhancer	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
MAR-BP1	NULL
shows	NULL
the	NULL
strongest	NULL
MAR-binding	NULL
activity	NULL
in	NULL
our	NULL
soluble	NULL
nuclear	NULL
matrix	NULL
preparation	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
MAR-BP1	NULL
seems	NULL
to	NULL
be	NULL
a	NULL
general	NULL
MAR-binding	NULL
protein	NULL
since	NULL
the	NULL
competition	NULL
experiments	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
indicate	NULL
that	NULL
it	NULL
interacts	NULL
with	NULL
a	NULL
number	NULL
of	NULL
other	NULL
MAR	NULL
regions	NULL
.	NULL

Nature	NULL
of	NULL
MAR-BP1	NULL
Binding-The	NULL
interaction	NULL
of	NULL
many	NULL
MAR	NULL
binding	NULL
proteins	NULL
,	NULL
including	NULL
MAR-BP1	NULL
,	NULL
with	NULL
DNA	NULL
appears	NULL
to	NULL
be	NULL
unusual	NULL
.	NULL

Although	NULL
MARs	NULL
have	NULL
a	NULL
characteristic	NULL
A/T-rich	NULL
se-quence	NULL
,	NULL
A/T	NULL
richness	NULL
per	NULL
se	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
matrix	NULL
attachment	NULL
since	NULL
poly	NULL
(	NULL
dA/dT	NULL
)	NULL
is	NULL
not	NULL
able	NULL
to	NULL
compete	NULL
for	NULL
matrix	NULL
attachment	NULL
(	NULL
von	NULL
Kries	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Romig	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
or	NULL
MARBP1	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

A	NULL
consensus	NULL
sequence	NULL
AATATATTT	NULL
seems	NULL
to	NULL
be	NULL
required	NULL
for	NULL
matrix	NULL
interaction	NULL
(	NULL
Mielke	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Laemmli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
;	NULL
however	NULL
,	NULL
the	NULL
important	NULL
aspect	NULL
of	NULL
this	NULL
sequence	NULL
is	NULL
probably	NULL
not	NULL
the	NULL
alternating	NULL
structure	NULL
since	NULL
mutations	NULL
toward	NULL
ATATATATA	NULL
give	NULL
poorer	NULL
MAR	NULL
activity	NULL
(	NULL
Laemmli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
types	NULL
of	NULL
homopolymeric	NULL
stretches	NULL
present	NULL
in	NULL
this	NULL
consensus	NULL
generate	NULL
a	NULL
relatively	NULL
narrow	NULL
minor	NULL
groove	NULL
(	NULL
Amati	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Zhao	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
and	NULL
it	NULL
may	NULL
be	NULL
that	NULL
*	NULL
R.-T.	NULL
Zong	NULL
and	NULL
R.	NULL
H.	NULL
Scheuermann	NULL
,	NULL
unpublished	NULL
results	NULL
.	NULL

MAR	NULL
Binding	NULL
and	NULL
IgH	NULL
Enhancer	NULL
Regulation	NULL
MAR-binding	NULL
proteins	NULL
recognize	NULL
this	NULL
type	NULL
of	NULL
structure	NULL
rather	NULL
than	NULL
a	NULL
specific	NULL
sequence	NULL
.	NULL

In	NULL
any	NULL
case	NULL
,	NULL
sequences	NULL
similar	NULL
to	NULL
this	NULL
consensus	NULL
can	NULL
be	NULL
found	NULL
in	NULL
all	NULL
four	NULL
NF-pNR	NULL
binding	NULL
sites	NULL
,	NULL
with	NULL
two	NULL
close	NULL
matches	NULL
in	NULL
both	NULL
P1	NULL
and	NULL
P2	NULL
,	NULL
and	NULL
a	NULL
perfect	NULL
match	NULL
in	NULL
P3	NULL
.	NULL

An	NULL
alternative	NULL
hypothesis	NULL
for	NULL
MAR/matrix	NULL
interaction	NULL
has	NULL
been	NULL
proposed	NULL
based	NULL
on	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
MARs	NULL
flanking	NULL
the	NULL
IgH	NULL
enhancer	NULL
assume	NULL
a	NULL
stable	NULL
unpaired	NULL
conformation	NULL
at	NULL
high	NULL
superhelical	NULL
density	NULL
,	NULL
that	NULL
extensive	NULL
base-unpairing	NULL
is	NULL
important	NULL
for	NULL
matrix	NULL
attachment	NULL
(	NULL
Kohwi-Shigematsu	NULL
and	NULL
Kowhi	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
idea	NULL
,	NULL
mutations	NULL
within	NULL
NF-wNR	NULL
site	NULL
P3	NULL
that	NULL
abolish	NULL
base-unpairing	NULL
also	NULL
adversely	NULL
affected	NULL
matrix	NULL
binding	NULL
in	NULL
vitro	NULL
(	NULL
Bode	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
)	NULL
.	NULL

These	NULL
results	NULL
imply	NULL
that	NULL
MAR-binding	NULL
proteins	NULL
would	NULL
show	NULL
preferential	NULL
interaction	NULL
with	NULL
single-stranded	NULL
DNA	NULL
.	NULL

However	NULL
,	NULL
while	NULL
MAR-BP1	NULL
binding	NULL
can	NULL
be	NULL
competed	NULL
by	NULL
double-stranded	NULL
P4	NULL
DNA	NULL
,	NULL
it	NULL
was	NULL
unaffected	NULL
by	NULL
either	NULL
single-stranded	NULL
P4	NULL
oligonucleotide	NULL
.	NULL
``	NULL

It	NULL
now	NULL
appears	NULL
that	NULL
MAR-binding	NULL
proteins	NULL
can	NULL
be	NULL
divided	NULL
into	NULL
two	NULL
groups	NULL
.	NULL

One	NULL
group	NULL
included	NULL
proteins	NULL
like	NULL
nucleolin	NULL
(	NULL
Dickinson	NULL
and	NULL
Kowhi-Shigematsu	NULL
,	NULL
1995	NULL
)	NULL
and	NULL
Lamin	NULL
B	NULL
(	NULL
Hakes	NULL
and	NULL
Berezney	NULL
,	NULL
1991	NULL
)	NULL
,	NULL
which	NULL
have	NULL
a	NULL
propensity	NULL
to	NULL
bind	NULL
single-stranded	NULL
DNA	NULL
.	NULL

The	NULL
other	NULL
group	NULL
includes	NULL
SATB1	NULL
and	NULL
MAR-BP1	NULL
,	NULL
which	NULL
bind	NULL
double-stranded	NULL
DNA	NULL
,	NULL
possibly	NULL
through	NULL
the	NULL
recognition	NULL
of	NULL
a	NULL
particular	NULL
tertiary	NULL
structure	NULL
such	NULL
as	NULL
a	NULL
narrow	NULL
minor	NULL
groove	NULL
.	NULL

The	NULL
binding	NULL
sites	NULL
for	NULL
several	NULL
MAR-binding	NULL
proteins	NULL
differ	NULL
from	NULL
the	NULL
recognition	NULL
sites	NULL
of	NULL
nuclear	NULL
transcription	NULL
factors	NULL
in	NULL
that	NULL
a	NULL
relative	NULL
large	NULL
fragment	NULL
(	NULL
~200	NULL
bp	NULL
)	NULL
is	NULL
required	NULL
for	NULL
high	NULL
affinity	NULL
binding	NULL
(	NULL
von	NULL
Kries	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
,	NULL
1994	NULL
;	NULL
Tsutsui	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Luderus	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
MAR-BP1	NULL
,	NULL
this	NULL
would	NULL
explain	NULL
why	NULL
removal	NULL
of	NULL
the	NULL
Xbal-Rsal	NULL
region	NULL
from	NULL
the	NULL
5'-end	NULL
of	NULL
the	NULL
5'-En	NULL
fragment	NULL
reduces	NULL
binding	NULL
affinity	NULL
by	NULL
a	NULL
factor	NULL
of	NULL
4	NULL
and	NULL
yet	NULL
has	NULL
no	NULL
intrinsic	NULL
affinity	NULL
for	NULL
MAR-BP1	NULL
itself	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
any	NULL
case	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
deletion	NULL
of	NULL
either	NULL
P1	NULL
or	NULL
P2	NULL
on	NULL
the	NULL
5'-En	NULL
fragment	NULL
,	NULL
or	NULL
P3	NULL
or	NULL
P4	NULL
on	NULL
the	NULL
3'-Ein	NULL
fragment	NULL
had	NULL
profound	NULL
effects	NULL
on	NULL
MAR-BP1	NULL
binding	NULL
suggesting	NULL
a	NULL
requirement	NULL
for	NULL
cooperative	NULL
interactions	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
these	NULL
sequences	NULL
serve	NULL
as	NULL
nucleation	NULL
sites	NULL
for	NULL
a	NULL
more	NULL
extensive	NULL
covering	NULL
of	NULL
the	NULL
region	NULL
by	NULL
multiple	NULL
MAR-BP1	NULL
proteins	NULL
.	NULL

This	NULL
could	NULL
explain	NULL
why	NULL
it	NULL
has	NULL
proven	NULL
difficult	NULL
to	NULL
footprint	NULL
these	NULL
,	NULL
or	NULL
any	NULL
,	NULL
DNA	NULL
regions	NULL
in	NULL
MAR-BP1	NULL
complexes	NULL
.	NULL

MARs	NULL
and	NULL
Transcription	NULL
Regulation-The	NULL
major	NULL
findings	NULL
from	NULL
this	NULL
work	NULL
can	NULL
be	NULL
summarized	NULL
as	NULL
follows	NULL
.	NULL

1	NULL
)	NULL
The	NULL
IgH	NULL
enhancer	NULL
repressor	NULL
protein	NULL
,	NULL
NF-pNR	NULL
,	NULL
is	NULL
able	NULL
to	NULL
inhibit	NULL
attachment	NULL
of	NULL
the	NULL
IgH	NULL
enhancer	NULL
to	NULL
the	NULL
nuclear	NULL
matrix	NULL
.	NULL

This	NULL
is	NULL
true	NULL
of	NULL
matrices	NULL
isolated	NULL
by	NULL
the	NULL
high	NULL
salt	NULL
method	NULL
(	NULL
Fig	NULL
.	NULL

64	NULL
)	NULL
or	NULL
the	NULL
LIS	NULL
method	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

2	NULL
)	NULL
A	NULL
33-kDa	NULL
DNA-binding	NULL
protein	NULL
,	NULL
MAR-BP1	NULL
,	NULL
has	NULL
been	NULL
isolated	NULL
from	NULL
nuclear	NULL
matrix	NULL
preparations	NULL
of	NULL
different	NULL
lymphoid	NULL
cell	NULL
types	NULL
,	NULL
which	NULL
bind	NULL
specifically	NULL
to	NULL
MAR	NULL
segments	NULL
derived	NULL
from	NULL
a	NULL
number	NULL
of	NULL
different	NULL
DNA	NULL
loci	NULL
.	NULL

3	NULL
)	NULL
Although	NULL
MAR-BP1	NULL
binding	NULL
sites	NULL
overlap	NULL
NF-uNR	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
IgH	NULL
enhancer	NULL
,	NULL
the	NULL
proteins	NULL
differ	NULL
in	NULL
molecular	NULL
weight	NULL
,	NULL
DNA	NULL
binding	NULL
characteristics	NULL
and	NULL
cell-type-specific	NULL
expression	NULL
profiles	NULL
.	NULL

4	NULL
)	NULL
NF-uNR	NULL
and	NULL
MAR-BP1	NULL
binding	NULL
are	NULL
mutually	NULL
exclusive	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
provide	NULL
support	NULL
for	NULL
a	NULL
model	NULL
of	NULL
NF-puNR-mediated	NULL
enhancer	NULL
regulation	NULL
involving	NULL
nuclear	NULL
matrix	NULL
attachment	NULL
previously	NULL
proposed	NULL
(	NULL
Scheuermann	NULL
and	NULL
Chen	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

In	NULL
this	NULL
model	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
an	NULL
important	NULL
aspect	NULL
of	NULL
IgH	NULL
enhancer	NULL
function	NULL
would	NULL
be	NULL
to	NULL
attach	NULL
the	NULL
heavy	NULL
chain	NULL
locus	NULL
to	NULL
the	NULL
nuclear	NULL
matrix	NULL
in	NULL
appropriate	NULL
cells	NULL
(	NULL
B	NULL
lymphocytes	NULL
)	NULL
.	NULL

This	NULL
would	NULL
bring	NULL
the	NULL
gene	NULL
into	NULL
regions	NULL
of	NULL
the	NULL
nucleus	NULL
that	NULL
contain	NULL
high	NULL
concentrations	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
RNA	NULL
polymerase	NULL
,	NULL
and	NULL
topoisomerases	NULL
.	NULL

However	NULL
,	NULL
in	NULL
inappropriate	NULL
cells	NULL
(	NULL
other	NULL
than	NULL
B	NULL
lymphocytes	NULL
)	NULL
NF-uNR	NULL
would	NULL
be	NULL
expressed	NULL
and	NULL
would	NULL
bind	NULL
to	NULL
its	NULL
recognition	NULL
sites	NULL
flanking	NULL
the	NULL
enhancer	NULL
,	NULL
thereby	NULL
preventing	NULL
nuclear	NULL
matrix	NULL
attachment	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10Â°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
MAR	NULL
Binding	NULL
and	NULL
IgH	NULL
Enhancer	NULL
Regulation	NULL
INACTIVE	NULL
{	NULL
non-B	NULL
cells	NULL
)	NULL
24017	NULL
ACTIVE	NULL
(	NULL
B	NULL
cells	NULL
)	NULL
Fic	NULL
.	NULL

9	NULL
.	NULL

A	NULL
model	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
IgH	NULL
enhancer	NULL
activity	NULL
through	NULL
differential	NULL
association	NULL
with	NULL
the	NULL
nuclear	NULL
matrix	NULL
.	NULL

Transcription	NULL
in	NULL
interphase	NULL
nuclei	NULL
is	NULL
apparently	NULL
organized	NULL
into	NULL
a	NULL
limited	NULL
number	NULL
of	NULL
focal	NULL
points	NULL
that	NULL
can	NULL
be	NULL
visualized	NULL
by	NULL
immunofluorescence	NULL
(	NULL
Jackson	NULL
ef	NULL
aZ	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

These	NULL
focal	NULL
points	NULL
contain	NULL
elongating	NULL
RNA	NULL
chains	NULL
,	NULL
RNA	NULL
polymerase	NULL
,	NULL
and	NULL
other	NULL
components	NULL
of	NULL
the	NULL
transcription	NULL
apparatus	NULL
.	NULL

These	NULL
focal	NULL
points	NULL
are	NULL
bound	NULL
to	NULL
a	NULL
matrix	NULL
present	NULL
within	NULL
the	NULL
nucleus	NULL
,	NULL
perhaps	NULL
at	NULL
areas	NULL
of	NULL
intersection	NULL
between	NULL
nuclear	NULL
matrix	NULL
filaments	NULL
.	NULL

DNA	NULL
is	NULL
bound	NULL
to	NULL
these	NULL
focal	NULL
regions	NULL
through	NULL
the	NULL
action	NULL
of	NULL
MAR-binding	NULL
proteins	NULL
(	NULL
Ã©riangles	NULL
)	NULL
like	NULL
MAR-BP1	NULL
.	NULL

In	NULL
B	NULL
cells	NULL
,	NULL
where	NULL
the	NULL
IgH	NULL
locus	NULL
is	NULL
transcriptionally	NULL
active	NULL
,	NULL
the	NULL
MARs	NULL
flanking	NULL
the	NULL
IgH	NULL
enhancer	NULL
are	NULL
bound	NULL
to	NULL
these	NULL
foci	NULL
facilitating	NULL
the	NULL
interaction	NULL
with	NULL
transcriptional	NULL
components	NULL
.	NULL

In	NULL
non-B	NULL
cells	NULL
,	NULL
where	NULL
the	NULL
locus	NULL
is	NULL
silent	NULL
,	NULL
the	NULL
MAR	NULL
sites	NULL
flanking	NULL
the	NULL
enhancer	NULL
are	NULL
bound	NULL
by	NULL
NF-uNR	NULL
(	NULL
spheres	NULL
labeled	NULL
N	NULL
)	NULL
preventing	NULL
the	NULL
IgH	NULL
locus	NULL
from	NULL
associating	NULL
with	NULL
the	NULL
focal	NULL
points	NULL
of	NULL
high	NULL
transcriptional	NULL
activity	NULL
.	NULL

This	NULL
model	NULL
implies	NULL
that	NULL
MARs	NULL
are	NULL
transcriptional	NULL
regulatory	NULL
elements	NULL
.	NULL

The	NULL
first	NULL
indications	NULL
that	NULL
MARs	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
transcription	NULL
came	NULL
from	NULL
the	NULL
observation	NULL
that	NULL
MARs	NULL
are	NULL
frequently	NULL
found	NULL
near	NULL
cis-acting	NULL
transcriptional	NULL
regulatory	NULL
elements	NULL
(	NULL
e.g	NULL
.	NULL

Gasser	NULL
and	NULL
Laemmli	NULL
,	NULL
1986	NULL
;	NULL
Cockerill	NULL
and	NULL
Garrard	NULL
,	NULL
1986	NULL
;	NULL
Cockerill	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
MARs	NULL
on	NULL
transcriptional	NULL
activity	NULL
has	NULL
revealed	NULL
an	NULL
interesting	NULL
characteristic	NULL
of	NULL
MARs	NULL
that	NULL
distinguish	NULL
them	NULL
from	NULL
promoter	NULL
and	NULL
enhancer	NULL
elements	NULL
.	NULL

MARs	NULL
have	NULL
been	NULL
found	NULL
to	NULL
stimulate	NULL
transcription	NULL
from	NULL
defined	NULL
promoters	NULL
in	NULL
a	NULL
number	NULL
of	NULL
systems	NULL
,	NULL
but	NULL
only	NULL
when	NULL
the	NULL
test	NULL
construct	NULL
is	NULL
stably	NULL
integrated	NULL
into	NULL
a	NULL
chro-mosomal	NULL
context	NULL
(	NULL
eg	NULL
.	NULL

Blasquez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Xu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Klehr	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
increasing	NULL
the	NULL
level	NULL
of	NULL
tran-scription	NULL
,	NULL
MARs	NULL
seem	NULL
to	NULL
provide	NULL
for	NULL
copy	NULL
number-dependent	NULL
and	NULL
position	NULL
independent	NULL
transcription	NULL
(	NULL
Phi-Van	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
McKnight	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Although	NULL
locus	NULL
control	NULL
regions	NULL
can	NULL
have	NULL
similar	NULL
effects	NULL
,	NULL
it	NULL
is	NULL
not	NULL
clear	NULL
whether	NULL
they	NULL
are	NULL
the	NULL
same	NULL
as	NULL
MARs	NULL
or	NULL
similar	NULL
(	NULL
Dillon	NULL
and	NULL
Grosveld	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

Some	NULL
evidence	NULL
suggests	NULL
that	NULL
MARs	NULL
might	NULL
play	NULL
a	NULL
role	NULL
in	NULL
tissue-specific	NULL
expression	NULL
regulation	NULL
.	NULL

Genes	NULL
that	NULL
are	NULL
actively	NULL
transcribed	NULL
are	NULL
preferentially	NULL
associated	NULL
with	NULL
the	NULL
nuclear	NULL
matrix	NULL
,	NULL
while	NULL
genes	NULL
that	NULL
are	NULL
not	NULL
expressed	NULL
are	NULL
not	NULL
bound	NULL
(	NULL
Gerdes	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
has	NULL
been	NULL
found	NULL
that	NULL
the	NULL
-globin	NULL
gene	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
nuclear	NULL
matrix	NULL
in	NULL
reticulocytes	NULL
but	NULL
not	NULL
in	NULL
thymocytes	NULL
,	NULL
whereas	NULL
the	NULL
malic	NULL
enzyme	NULL
gene	NULL
is	NULL
attached	NULL
in	NULL
thymocytes	NULL
but	NULL
not	NULL
reticulocytes	NULL
(	NULL
Brotherton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
demonstrates	NULL
that	NULL
tissue-specific	NULL
nuclear	NULL
matrix	NULL
attachment	NULL
correlates	NULL
with	NULL
tissue-specific	NULL
transcriptional	NULL
expression	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
the	NULL
IgH	NULL
intronic	NULL
enhancer	NULL
,	NULL
a	NULL
recent	NULL
publication	NULL
provides	NULL
strong	NULL
support	NULL
for	NULL
the	NULL
importance	NULL
of	NULL
these	NULL
MAR	NULL
regions	NULL
in	NULL
transcriptional	NULL
enhancement	NULL
(	NULL
Forrester	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
the	NULL
IgH	NULL
enhancer	NULL
to	NULL
stimulate	NULL
expression	NULL
of	NULL
a	NULL
rearranged	NULL
Ig	NULL
heavy	NULL
chain	NULL
transgene	NULL
was	NULL
examined	NULL
in	NULL
preB	NULL
cell	NULL
lines	NULL
isolated	NULL
from	NULL
transgenic	NULL
mice	NULL
in	NULL
which	NULL
the	NULL
transgene	NULL
contained	NULL
a	NULL
wild-type	NULL
enhancer	NULL
or	NULL
an	NULL
enhancer	NULL
with	NULL
MAR	NULL
site	NULL
deletions	NULL
.	NULL

While	NULL
all	NULL
preB	NULL
cell	NULL
lines	NULL
from	NULL
mice	NULL
containing	NULL
the	NULL
wild-type	NULL
enhancer	NULL
exhibited	NULL
high	NULL
level	NULL
transgene	NULL
expression	NULL
,	NULL
transgene	NULL
expression	NULL
was	NULL
absent	NULL
in	NULL
lines	NULL
from	NULL
MAR	NULL
deletion	NULL
mutants	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
,	NULL
in	NULL
mice	NULL
,	NULL
IgH	NULL
enhancer	NULL
activity	NULL
requires	NULL
intact	NULL
MARs	NULL
.	NULL

As	NULL
NF-uNR	NULL
is	NULL
only	NULL
expressed	NULL
in	NULL
non-B	NULL
cells	NULL
and	NULL
can	NULL
prevent	NULL
nuclear	NULL
matrix	NULL
attachment	NULL
in	NULL
vitro	NULL
,	NULL
the	NULL
cell-type-specificity	NULL
of	NULL
the	NULL
IgH	NULL
enhancer	NULL
may	NULL
in	NULL
part	NULL
be	NULL
controlled	NULL
by	NULL
the	NULL
negative	NULL
regulation	NULL
of	NULL
nuclear	NULL
matrix	NULL
attachment	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Phil	NULL
Tucker	NULL
and	NULL
Bill	NULL
Garrard	NULL
for	NULL
plasmid	NULL
constructs	NULL
and	NULL
helpful	NULL
discussions	NULL
throughout	NULL
the	NULL
course	NULL
of	NULL
this	NULL
work	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Danielle	NULL
Lenig	NULL
for	NULL
technical	NULL
assistance	NULL
during	NULL
the	NULL
early	NULL
phases	NULL
of	NULL
this	NULL
project	NULL
.	NULL

REFERENCES	NULL
Amati	NULL
,	NULL
B.	NULL
,	NULL
Pick	NULL
,	NULL
L.	NULL
,	NULL
Laroche	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Gasser	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
4007-4016	NULL
Berezney	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Biochem	NULL
.	NULL

47	NULL
,	NULL
109-123	NULL
Berezney	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Coffey	NULL
,	NULL
D.	NULL
(	NULL
1974	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

60	NULL
,	NULL
1410-1417	NULL
Bidwell	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
van	NULL
Wijnen	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Fey	NULL
,	NULL
E.	NULL
D.	NULL
,	NULL
Dworetzky	NULL
,	NULL
S.	NULL
,	NULL
Penman	NULL
,	NULL
S.	NULL
,	NULL
.	NULL

Lian	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Stein	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Stein	NULL
,	NULL
G.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
3162-3166	NULL
Blasquez	NULL
,	NULL
V.	NULL
C.	NULL
,	NULL
Xu	NULL
,	NULL
M.	NULL
,	NULL
Moses	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
and	NULL
Garrard	NULL
,	NULL
W.	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
21183-21189	NULL
Bode	NULL
,	NULL
J.	NULL
,	NULL
Kohwi	NULL
,	NULL
Y.	NULL
,	NULL
Dickinson	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Job	NULL
,	NULL
T.	NULL
,	NULL
Klebr	NULL
,	NULL
D.	NULL
,	NULL
Mielke	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Kohwi-Shigematsu	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
255	NULL
,	NULL
195-197	NULL
Bradford	NULL
,	NULL
M.	NULL
M.	NULL
(	NULL
1976	NULL
)	NULL
Anal	NULL
Biochem	NULL
.	NULL

72	NULL
,	NULL
248-254	NULL
Brotherton	NULL
,	NULL
T.	NULL
,	NULL
Zenk	NULL
,	NULL
D.	NULL
,	NULL
Kahanic	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Reneker	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Biochemistry	NULL
80	NULL
,	NULL
5845-5850	NULL
Cockerill	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
and	NULL
Garrard	NULL
,	NULL
W.	NULL
T.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
44	NULL
,	NULL
273-282	NULL
Cockerill	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
Yuen	NULL
,	NULL
M.-H.	NULL
,	NULL
and	NULL
Garrard	NULL
,	NULL
W.	NULL
T.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262	NULL
,	NULL
5394-5397	NULL
Dillon	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Grosveld	NULL
,	NULL
F.	NULL
(	NULL
1993	NULL
)	NULL
Trends	NULL
Genet	NULL
.	NULL

9	NULL
,	NULL
134-137	NULL
Dickinson	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
and	NULL
Kohwi-Shigematsu	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
456-465	NULL
Dickinson	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Joh	NULL
,	NULL
Y.	NULL
,	NULL
Kohwi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Kohwi-Shigematsu	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
70	NULL
,	NULL
631-645	NULL
Fackelmayer	NULL
,	NULL
F.	NULL
O.	NULL
,	NULL
Dahm	NULL
,	NULL
K.	NULL
,	NULL
Renz	NULL
,	NULL
A.	NULL
,	NULL
Ramsperger	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Richter	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

221	NULL
,	NULL
749-757	NULL
Fey	NULL
,	NULL
E.	NULL
G.	NULL
,	NULL
and	NULL
Penman	NULL
,	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
121-125	NULL
Fried	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Crothers	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
1981	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

9	NULL
,	NULL
3047-3060	NULL
Forrester	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
van	NULL
Genderen	NULL
,	NULL
C.	NULL
,	NULL
Jenuwein	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Grosschedl	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
265	NULL
,	NULL
1221-1225	NULL
Garner	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Revzin	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

9	NULL
,	NULL
3047-3060	NULL
Gasser	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
521-530	NULL
Gerdes	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Carter	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
Moen	NULL
,	NULL
P.	NULL
T.	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
Lawrence	NULL
,	NULL
J	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

126	NULL
,	NULL
289-304	NULL
Giese	NULL
,	NULL
K.	NULL
,	NULL
Amsterdam	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Grosschedl	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
2567-2578	NULL
Hakes	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
and	NULL
Berezney	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
11131-11140	NULL
Hofmann	NULL
,	NULL
J	NULL
.	NULL

F.-X	NULL
.	NULL

,	NULL
Laroche	NULL
,	NULL
T.	NULL
,	NULL
Brand	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
and	NULL
Gasser	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
57	NULL
,	NULL
725-737	NULL
Jackson	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Hassan	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
Errington	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Cook	NULL
,	NULL
P.	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
1059-1065	NULL
Kim	NULL
,	NULL
J.	NULL
,	NULL
Zwieb	NULL
,	NULL
C.	NULL
,	NULL
Wu	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Adhya	NULL
,	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Gene	NULL
(	NULL
Amst	NULL
.	NULL
)	NULL

85	NULL
,	NULL
15-23	NULL
Klehr	NULL
,	NULL
D.	NULL
,	NULL
Maass	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Bode	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Biochemistry	NULL
80	NULL
,	NULL
1264-1270	NULL
Kohwi-Shigematsu	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Kohwi	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Biochemistry	NULL
29	NULL
,	NULL
9551-9560	NULL
Laemuli	NULL
,	NULL
U.	NULL
K.	NULL
(	NULL
1970	NULL
)	NULL
Nature	NULL
227	NULL
,	NULL
680-685	NULL
Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
,	NULL
Kas	NULL
,	NULL
E.	NULL
,	NULL
Poljak	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Adachi	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

2	NULL
,	NULL
275-285	NULL
Luderus	NULL
,	NULL
M.	NULL
E.	NULL
E.	NULL
,	NULL
de	NULL
Graaf	NULL
,	NULL
A.	NULL
,	NULL
Mattia	NULL
,	NULL
E.	NULL
,	NULL
den	NULL
Blaauwen	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Grande	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
de	NULL
Jong	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
van	NULL
Driel	NULL
,	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
70	NULL
,	NULL
949-959	NULL
Luderus	NULL
,	NULL
M.	NULL
E.	NULL
E.	NULL
,	NULL
van	NULL
Blaauwen	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
de	NULL
Smith	NULL
,	NULL
O.	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Compton	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
and	NULL
van	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10Â°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
24018	NULL
MAR	NULL
Binding	NULL
and	NULL
IgH	NULL
Enhancer	NULL
Regulation	NULL
Driel	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
6297-6305	NULL
McKnight	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Shamay	NULL
,	NULL
A.	NULL
,	NULL
Sankaran	NULL
,	NULL
L.	NULL
,	NULL
Wall	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Hennighausen	NULL
,	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
6943-6947	NULL
Mielke	NULL
,	NULL
C.	NULL
,	NULL
Kohwi	NULL
,	NULL
Y.	NULL
,	NULL
Kohwi-Shigematsu	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Bode	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Biochemistry	NULL
29	NULL
,	NULL
7475-7485	NULL
Nakagomi	NULL
,	NULL
K.	NULL
,	NULL
Kohwi	NULL
,	NULL
Y.	NULL
,	NULL
Dickinson	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
and	NULL
Kohwi-shigematsu	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
1852-1860	NULL
Phi-van	NULL
,	NULL
L.	NULL
,	NULL
von	NULL
Kries	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Ostertag	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Stratling	NULL
,	NULL
W.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
2302-2307	NULL
Romig	NULL
,	NULL
H.	NULL
,	NULL
Fackelmayer	NULL
,	NULL
F.	NULL
O.	NULL
,	NULL
Renz	NULL
,	NULL
A.	NULL
,	NULL
Ramsperger	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Richter	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
3431-3440	NULL
Scheuermann	NULL
,	NULL
R.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
in	NULL
Immunol	NULL
.	NULL

Methods	NULL
(	NULL
Lefkovits	NULL
,	NULL
I.	NULL
,	NULL
&	NULL
Pernis	NULL
,	NULL
B.	NULL
,	NULL
eds	NULL
)	NULL
Vol	NULL
.	NULL

IV	NULL
,	NULL
pp	NULL
75-93	NULL
,	NULL
Academic	NULL
Press	NULL
,	NULL
San	NULL
Diego	NULL
Scheuermann	NULL
,	NULL
R.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
624-634	NULL
Scheuermann	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
and	NULL
Chen	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

8	NULL
,	NULL
1255-1266	NULL
Sperry	NULL
,	NULL
A.	NULL
O.	NULL
,	NULL
Blasquez	NULL
,	NULL
V.	NULL
C.	NULL
,	NULL
and	NULL
Garrard	NULL
,	NULL
W.	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
5497-5501	NULL
Staudt	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
Lenardo	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

9	NULL
,	NULL
373-398	NULL
Stief	NULL
,	NULL
A.	NULL
,	NULL
Winter	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Stratling	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
and	NULL
Sippel	NULL
,	NULL
A.	NULL
E.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
341	NULL
,	NULL
343-345	NULL
Tsutsui	NULL
,	NULL
K.	NULL
,	NULL
Tsutsui	NULL
,	NULL
K.	NULL
,	NULL
Okada	NULL
,	NULL
S.	NULL
,	NULL
Waterai	NULL
,	NULL
S.	NULL
,	NULL
Seki	NULL
,	NULL
S.	NULL
,	NULL
Yasuda	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Shohmori	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
12886-12894	NULL
von	NULL
Kries	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Bubrmester	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Stratling	NULL
,	NULL
W.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
123-135	NULL
von	NULL
Kries	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Buck	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Stratling	NULL
,	NULL
W.	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22	NULL
,	NULL
1215-1220	NULL
Webb	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
Das	NULL
,	NULL
C.	NULL
,	NULL
Eneff	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
and	NULL
Tucker	NULL
,	NULL
P.	NULL
W.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
5206-5211	NULL
Xu	NULL
,	NULL
M.	NULL
,	NULL
Hammer	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Blasquez	NULL
,	NULL
V.	NULL
C.	NULL
,	NULL
Jones	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
Garrard	NULL
,	NULL
W.	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
21190-21195	NULL
Zhao	NULL
,	NULL
K.	NULL
,	NULL
Kas	NULL
,	NULL
E.	NULL
Gonzalez	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
3237-3247	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10Â°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Mutually	NULL
Exclusive	NULL
Interaction	NULL
of	NULL
a	NULL
Novel	NULL
Matrix	NULL
Attachment	NULL
Region	NULL
Binding	NULL
Protein	NULL
and	NULL
the	NULL
NF-	NULL
NR	NULL
Enhancer	NULL
Repressor	NULL
:	NULL
IMPLICATIONS	NULL
FOR	NULL
REGULATION	NULL
OF	NULL
IMMUNOGLOBULIN	NULL
HEAVY	NULL
CHAIN	NULL
EXPRESSION	NULL
Rui-Ting	NULL
Zong	NULL
and	NULL
Richard	NULL
H.	NULL
Scheuermann	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1995	NULL
,	NULL
270:24010-24018.	NULL
doi	NULL
:	NULL
10.1074/jb0.270.41.24010	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/270/41/24010	NULL
Alerts	NULL
:	NULL
Â«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
Â«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
48	NULL
references	NULL
,	NULL
20	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10Â°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

